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Manganese (Mn) neurotoxicity has been recognized for a long time and it
affects primarily the basal ganglia. However, only recently has inflammation, which is
known to play an important role in neuropathology, been considered as part of its
toxic mechanism. In the current study, we have shown that Mn-potentiation of
inflammatory cytokines ( IL-6 and TNF-α) in microglia is not dependent on the activation
of the Toll-like receptor (TLR)-4 signaling pathway by lipopolysaccharide (LPS), as
potentiation by Mn is observed in microglia activated with agonists for other TLR, such
as TLR2, TLR3, and TLR9. Furthermore, enhancement of inflammatory cytokine
production by Mn is independent of the MyD88 signaling pathway, as Mn-potentiation

in TLR3-activated microglia occurs by a signaling pathway which is MyD88independent.
Additionally, inhibition of p38, ERK, or JNK mitogen-activated protein
kinases (MAPK) prevented Mn-potentiation, which suggest that these MAPK are
required for potentiation of inflammatory cytokines by Mn. We also observed that Mn
exposure results in persistent activation of p38. The prolonged activation of p38 may be
due to increased activation of the ‘upstream’ MAPK, mitogen-activated protein kinase
kinase (MKK)-1/2 or MKK-4, or to decreased expression of the phosphatase, mitogenactivated protein kinase phosphatase-1 (MKP-1), that is responsible for deactivating p38.
Overall, it appears that Mn potentiates microglial inflammatory cytokine output
in conjunction with diverse stimuli by an unknown mechanism, but likely involving
MAPK and perhaps extending their activation, that of p38 in particular. This ability of
Mn to potentiate brain inflammation should be considered as part of its neurotoxic
mechanism.
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CHAPTER I
INTRODUCTION
Overview of metal toxicity
The use of metals has been an important facet of human society since the end of
the Stone Age of man. From tools for agriculture to weapons of war, metals have been
applied to many uses, including therapeutics for ailments and disease. Indeed, it is
perhaps the medicinal uses that first illustrated the toxicity that could occur from
prolonged or excessive metal exposures (Koehler, 2001). Metal organ system toxicities
include adverse effects of cadmium on the endocrine and renal systems (Fowler, 1993;
Henson and Chedrese, 2004), and those of chromium on the hepatic, renal, and
respiratory systems (Wedeen and Qian, 1991). Of the organ system toxicities that
excessive metal exposure can manifest itself with, it is perhaps the nervous system that is
most sensitive. Metal neurotoxicity has been documented and studied for several metals,
including copper (Cu), iron (Fe), manganese (Mn), mercury (Hg) and lead (Pb;
Gutteridge, 1992; Stankiewicz et al., 2007; White et al., 2007; Wright and Baccarelli,
2007). Generally, the mechanism(s) of toxicity for these metals includes either binding
to cellular proteins (i.e. Hg and Pb), or induction of oxidative stress within the exposed
tissue (i.e. Cu, Fe, and Mn; Stankiewicz et al., 2007; Wright and Baccarelli, 2007). It is
the ability of transitions metals, like Mn, to promote oxidative stress within the nervous
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system that has become an area of research, as CNS oxidative stress may be important in
the initiation of neurological diseases such as Parkinson’s Disease (Dobson et al., 2004).
Essentiality, routes of exposure, and bioavailability of manganese
In modern times, Mn is encountered in mining and the smelting of metals, alloy
industry, as a component of the fuel additive methylcyclopentadienyl manganese
tricarbonyl (MMT), and in pesticides such as manganese ethylene bisdithiocarbamate
(Maneb; Frumkin and Solomon, 1997; Aschner, 2000). Additionally, Mn is an essential
dietary component and trace amounts are necessary for many physiological processes
including synthesis of amino acids, lipids, proteins, and carbohydrates (Finley and Davis,
1999). Toxicologically, oral exposure to Mn is not a major route of exposure due to the
low concentrations found in most foods and the limited transport by the gastrointestinal
system (1-5%; Davidsson et al., 1988; Davis et al., 1993). Although parenteral nutrition
may increase the exposure risk to Mn, typically this form of nutritional intake is only
performed in controlled medical settings and on a limited basis (Wright and Baccarelli,
2007). Other potential routes of Mn exposure include the skin, a relatively impermeable
barrier to charged particles, and the respiratory system. The absorption of Mn by the
olfactory nerve and lungs is largely dependent on particle solubility (MnSO4>Mn3(PO4)4) and this route of exposure, in terms of neurotoxicity, is toxicologically relevant
(Roels et al., 1997; Dorman et al., 2001). Significant concentrations of Mn in the air can
be found near industries involved in ferroalloy production, iron and steel foundries, and
from power plant emissions (Lioy, 1983). Indeed, processing of Mn-containing ores
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resulted in the first recorded Mn-caused neurotoxicity (reviewed by Aschner and
Aschner, 1991).
Manganese toxicity and manganism
In 1837 ore grinders exposed to Mn dust exhibited extrapyramidal dysfunction
with neuropsychiatric symptomatology referred to as “locura manganica” or
“manganism” (reviewed by Aschner and Aschner, 1991). The overall effect of Mn on the
central nervous system (CNS) is still not well understood. However, it has been
demonstrated that Mn-induced neuropathology is similar to another neurological disorder
of unknown etiology, Parkinson’s Disease (PD). The study of this neurological disease
has, in part, furthered our understanding of Mn neurotoxicity.
Parkinson’s disease
In the early 19th century, the English physician James Parkinson described a
shaking palsy in several patients (reviewed by Kempster et al., 2007). This disease would
later come to bear his name. Although little progress was made in understanding PD over
the next 100 years, the Swedish neuroscientist, Arvid Carlsson, proposed in the 1960’s
that PD was the result of damage to the dopaminergic neurons in a region of the midbrain
responsible for coordinating voluntary movement (Carlsson, 2001). This hypothesis was
later shown to be correct and successful treatments were devised including the use of LDopa, one of the precursors necessary for the synthesis of dopamine (Carlsson, 2001).
The study of PD has demonstrated the sensitivity of the dopamine-producing neurons to
stressors, particularly oxidative stress (Dobson et al., 2004; HaMai and Bondy, 2004).
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In fact, as discussed below, it is oxidative stress that is thought to be partially responsible
for the direct effects of Mn on dopaminergic neurons (Dobson et al., 2004; HaMai and
Bondy, 2004).
Mechanisms of manganese neurotoxicity
The sensitivity of dopaminergic neurons to Mn is partially attributed to the ability
of Mn to interact with the catechols, such as dopamine and its precursors/metabolites,
leading to their oxidation and generation of the reactive intermediates, and, ultimately,
cell death (Graham et al., 1978; Donaldson et al., 1982; Archibald and Tyree, 1987;
Sistrunk et al., 2007). Alternatively, Mn has been shown to exert toxicity on neurons by
directly disrupting neuronal mitochondrial respiration, leading to decreased ATP
production and oxidative stress (Aschner and Aschner, 1991; Gavin et al., 1999). This is
supported by studies demonstrating that Mn-containing compounds, such as the fungicide
Maneb and the fuel additive MMT, can inhibit mitochondrial respiration (Autissier et al.,
1977; Zhang et al., 2003). Perturbation of mitochondrial function apparently is not
limited to dopaminergic neurons as other neuronal types, e.g. striatal GABA interneurons
are affected by Mn exposure (Liu et al., 2006).
These effects are, in part, attributed to transport mechanisms that favor the influx,
but not the efflux, of Mn into the mitochondria (Gunter et al., 1994; HaMai and Bondy,
2004). Although research examining the ability of Mn, or other stressors, to directly
damage neurons has been conducted, another potential target for Mn-induced
neurotoxicity are two of the CNS glial cells, astroglia and microglia.
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Inflammation and manganese
In the CNS, both astroglia and microglia are found in close proximity to neuronal
cells. However, while astrocytes are uniformly distributed throughout the brain,
microglial cells are not. In fact, areas of the brain affected by Mn, such as the striatum
and the substantia nigra have more microglia than areas that appear to be less affected,
i.e., brain stem and cerebellum (Lawson et al., 1990; Savchenko et al., 2000).
Recent publications have demonstrated the ability of Mn to stimulate, or
augment, the ability of glial cells to produce inflammatory mediators that can damage
surrounding neuronal cells. Astroglia, for example, accumulate Mn and can produce
reactive oxygen species (ROS) and other substances that may be damaging to neurons
(Aschner, 2000). Microglia are producers of several key inflammatory cytokines, such as
TNF-α, and they are the major producers of this cytokine in the CNS (Kim and de Vellis,
2005). Moreover, as stated, it has been demonstrated that microglia and/or astroglia
produce inflammatory mediators and microglia-derived mediators can stimulate
astrocytes, thus creating a vicious inflammatory cycle. Such inflammatory cycle may be
involved in the mechanisms of Mn neurotoxicity, especially in cases where an additional
inflammatory stimulus leads to the activation of glial cells (Chang and Liu, 1999; Filipov
et al., 2005; Spranger et al., 1998).
Due to the ability of microglial cells to process antigen for presentation to other
cells of the immune system, as well as their ability to produce a diverse array of
cytokines and immunological factors, microglia are considered the primary immune
effector cells of the CNS (Perry et al., 1998; Kreutzberg, 1996; Kim and de Vellis, 2005).
Thus, it is possible that at least part of the Mn-induced neuronal toxicity is the result of
5

inappropriate, or inopportune, activation of the microglial cells, leading to enhanced and
prolonged synthesis of inflammatory mediators and ensuing neuronal damage.
Activation of microglial cells may also occur as a consequence of neuronal cell
damage or death. The release of neuronal cellular components like heat shock proteins
and ATP have been shown to activate microglial cells (Kakimura et al., 2002; Shimizu et
al., 2005; Potucek et al., 2006; Light et al., 2006). Alternatively, infection of the CNS by
viral agents such as vesicular stomatitis virus and HIV has been shown to induce the
(primarily) microglial production of inflammatory molecules such as nitric oxide (NO)
and cytokines directly (Epstein and Gelbard, 1999). Additionally, systemic infection or
peripheral inflammogen administration can activate CNS microglia, an effect of
significant consequence in the presence of active neurodegeneration (Cunningham et al.,
2005), particularly in the aged (Godbout et al., 2005). On the other hand, activation of
microglia can occur in the absence of infection. Exposure to the model PD toxicant, 1methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is associated with microglial
activation (McGeer et al., 2003). Indeed, it is the potential for microglial activation by
the previously listed mechanisms that explains the use of microglial activators, such as
MPTP and bacterial lipopolysaccharide (LPS), in experimental models of PD or Mn
neurotoxicity.
Microglia and Parkinson’s Disease-like neuropathology
Early studies examining the role of microglia in PD-like neurotoxicity utilized the
model PD toxicant MPTP. In both human and animal exposures to MPTP, prolonged
activation of microglial cells was demonstrated long after exposure to MPTP had ended
6

(McGeer et al., 2003). Additionally, it has been demonstrated that prior exposure to Mn
before challenge with MPTP will result in greater basal ganglia pathology than exposure
to Mn or MPTP alone (Takahashi et al., 1989).
Since exposure to MPTP has been largely limited to i.v. drug users and laboratory
animals, the relevance of this exposure model in the context of co-exposure to Mn
becomes questionable. Although MPTP is a potent activator of microglia, a more
relevant microglial activator may be lipopolysaccharide (LPS), a cell-wall component of
Gram-negative bacteria. LPS is a common environmental contaminant and model
inflammogen due to its ability to stimulate microglia to produce cytokines, NO, and ROS
(Chao et al., 1992; Jeohn et al., 2002b; Liu et al., 2002). Indeed, binding of LPS to the
recently discovered Toll-like Receptor 4 (TLR4) has been shown to be key for activation
of cells of the innate immune system, including microglia (Bhat et al., 1998; Jeohn et al.,
2002a; Medzhitov and Janeway, 1997; Takeda and Akira, 2004).
Toll-like receptors, intracellular signaling and inflammation
The discovery of the Toll-like receptor (TLR) family of proteins fundamentally
changed the perceived role of the innate immune system. Interestingly, the initial finding
that led to the discovery of the TLR family of proteins was not the result of
experimentation in a typical animal model of innate immunity, rodent (mouse or rat), but
in the developmental biology of the fruit fly, Drosophila melanogaster. Indeed, it was
the discovery of the molecule Toll, which is required for the development of dorsalventral polarity in the fruit fly embryo, as well as fly immune responses to fungal
pathogens, that led to the discovery of the TLR family of proteins (Anderson et al., 1985;
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Hashimoto et al., 1988; Lemaitre et al., 1996; Takeda and Akira, 2004; Beutler, 2004).
Importantly, the discovery of the TLR molecules demonstrated that innate immune
responses are not merely primitive and nonspecific, but are surprisingly complex and
highly specific (Beutler, 2004; Takeda and Akira, 2004). Moreover, it has been
suggested that TLR-mediated innate immunity is not only the first line of defense against
invading pathogens, but that TLR are, possibly, the most important receptors in initiating
both innate and adaptive immune responses (Beutler, 2004).
Although it is the recognition of pathogen-associated molecular patterns (PAMP)
such as Gram negative bacterial LPS, viral RNA (polyinosinic:polycytidylic acid; pI:C),
viral DNA (Cytosine Guanine linear dinucleotide; CpG), or Gram positive bacterial
peptidoglycan (peptidoglycan from Staphylococcus aureus; GPG) by their TLR (TLR4,
TLR3, TLR2, and TLR9, respectively) that initiate innate immunity and inflammation, it
is the intracellular signal transduction pathways that control the expression/production of
immune and inflammatory mediators (Beutler, 2004; Takeda and Akira, 2004).
Generally speaking, TLR intracellular signaling is a series of activation events linking the
TLR to adaptor molecules such as myeloid differentiation primary-response protein 88
(MyD88) or Toll-receptor-associated activator of interferon (TRIF), which subsequently
activate primary kinases (Interleukin-1-receptor-associated kinase [IRAK], transforming
growth factor-β activating kinase-1 [TAB1], TNF-receptor-associated factor 6 [TRAF6]
or TRAF-family-member-associated NF-kB activator-binding kinase 1 [TBK1], and
secondary signaling kinases Mitogen activated protein kinases; [MAPK]). Ultimately,
these events lead to the activation of one or more transcription factors such as NF-kB,
activator protein-1 (AP-1), or signal transducer and activator of transcription I (STAT I)
8

that induce inflammatory mediator mRNA expression and, in the case of inflammatory
cytokines, subsequent protein production and release (Beutler, 2004; Takeda and Akira,
2004).
The specific signaling molecules induced by TLR-PAMP interaction are
dependent on the TLR. For instance, TLR3-mediated intracellular signaling is
independent of MyD88, instead requiring TRIF for initiation of intracellular signaling
(Beutler, 2004; Kawai and Akira, 2006). In contrast, TLR2, TLR4, and TLR9 induce
signaling via MyD88 (Beutler, 2004; Takeda and Akira, 2004). However, only TLR2
and TLR9 are entirely dependent on MyD88, as TLR4 can initiate intracellular signaling
by both MyD88-dependent and MyD88-independent (i.e. TRIF) pathways (Beutler, 2004;
Takeda and Akira, 2004). For MyD88-dependent signaling, activation of the primary
kinases, including IRAK, TRAF6 and TAK1, leads to the activation of the MAPK and
NF-kB, while TRIF (MyD88-independent) signaling activates TBK and IRF3, leading to
the activation of the STAT I transcription factor (Beutler, 2004; Takeda and Akira, 2004).
Although TLR-induced intracellular signaling has been examined for several
TLRs, the key role of TLR in both cellular innate immunity and inflammation is perhaps
best illustrated by the first TLR-PAMP to be described, TLR4-LPS. Indeed, it was the
observation that C3H/HeJ and C57BL/10ScCr mouse strains are resistant to LPS-induced
endotoxic shock, but susceptible to gram negative bacterial infection (e.g. LPScontaining bacteria), that led to the discovery of TLR4 as the receptor for LPS (Poltorak
et al., 1998). Typically, binding of LPS to TLR4 leads to the association of the MyD88
adaptor protein (Figure 1-1). Subsequently, MyD88 recruits IRAK-1 and IRAK-4,
serine-threonine kinases that phosphorylate TRAF6 (Beutler, 2004; Figure 1-1).
9

Activation of TRAF6 by IRAK-1/4 leads to the activation of the MAP3K TAK-1, leading
to the activation of the MAPK cascade (Beutler, 2004; Takeda and Akira, 2004; Figure 11).
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Figure 1-1

LPS signaling via the TLR4 receptor.

Figured adapted from Beutler (2004). Abbreviations: TLR (Toll-like receptors), MyD88
(myeloid differentiation factor 88), Mal/TIRAP (MyD88-Toll/Interluekin-1 receptor
region adaptor protein), TRAM (Toll-receptor-associated molecule), TRIF (Tollreceptor-associated activator of interferon), IRAK (Interleukin-1 receptor-associated
receptor kinase), TRAF (TNF-receptor-associated factor), TAK1 (Transforming-growthfactor-β-activated kinase), TAB (TAK1-binding protein), TBK (TRAF-family-memberassociated NF-kB activator-binding kinase), IRF3 (Interferon-regulatory factor 3), IKK(Inhibitor of nuclear factor-kB-kinase complex), NF-kB (nuclear factor-kB), MAPK
(Mitogen-activated protein kinase), ERK (Extracellular regulated kinase), JNK (c-JUN nterminal kinase), TBP (TATA-binding protein).
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Once activated, TAK-1 phosphorylates the MAP2K (i.e. MEK-1/2, MEK-3/6, and
MEK-4) which phosphorylate the MAPK, resulting in the initiation of cellular processes,
including gene transcription (Seger and Krebs, 1995; Koistinaho and Koistinaho, 2002;
Figure 1-2). The MAPK are composed of the extracellular signal-regulated kinases
(ERK), stress-activated or c-Jun N-terminal kinases (SAPK/JNK), big MAPK 1 (BMK1),
and the p38 MAPK (Seger and Krebs, 1995). Regulation of the MAPK cascade occurs
by activation by ‘upstream’ MAP2K, as well as dephosphorylation of the MAPK due to
the actions of phosphatases, such as the dual specificity phosphatases (DUSP; Camps et
al., 2000). The DUSP dephosphorylate the MAPK at one or both phosphorylation sites,
leading to the deactivation of the MAPK (Camps et al., 2000). Of these MAPK, p38
MAPK (p38) and ERK appear to be primarily involved in the production of inflammatory
mediators by microglia (Koistinaho and Koistinaho, 2002).

12

Figure 1-2

The MAPK Cascade
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Microglial models of inflammation: mechanisms
In primary microglia and microglial cell lines, LPS has been shown to dose- and
time-dependently increase the phosphorylation of ERK, JNK, and p38, as well as
increase the expression of iNOS, TNF-α, and Cox-2 (Bhat et al., 1998; Lee et al., 1994;
Lee et al., 1993; Waetzig et al., 2005). However, the p38-dependent increases in NO
production require not only the phosphorylation of p38 but increased kinase activity as
well (Jeohn et al., 2002b).
Additionally, by exposing microglia to ERK- and p38-inhibitors prior to exposure
to LPS, the LPS-induced increases in NO and TNF-α were inhibited (Bhat et al., 1998).
Furthermore, LPS-induced, p38-dependent, increases in NO and TNF-α by microglia
have been shown to decrease neuronal survivability in neuronal-glial co-culture, an effect
that can be inhibited by pretreatment with inhibitors of p38 (Jeohn et al., 2002b).
However, TLR expression and inflammatory cytokine production by microglia is not
limited to TLR4, as microglia express mRNA for TLR 1-9 (Olson and Miller, 2004; Jack
et al., 2005), with 2, 3, 4, and 9 being the most abundant (Olson and Miller, 2004; Jack et
al., 2005). Furthermore, microglia produce IL-6 and TNF-α, as well upregulate cellsurface molecules such as major histocompatibility complex-II and costimulatory
molecules including CD-40, CD-45, and CD-11b (Olson and Miller, 2004).
Manganese, microglia, and inflammation
Although inflammatory responses are essential for the maintenance and defense
of tissues, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis,
especially in sensitive tissues such as the nervous system. In fact, abnormally high levels
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of inflammatory cytokines, such as TNF-α, have been implicated in the etiology of PD
(Nagatsu et al., 2000). Within the context of Mn neurotoxicity, Mn enhances the
production of inflammatory mediators by microglia, as exposure to Mn potentiates LPSinduced production of TNF-α, IL-6 (Filipov et al., 2005) and NO (Chang and Liu, 1999;
Filipov et al., 2005) in vitro. Additionally, this effect is NF-kB-dependent as inhibitors
of NF-kB were able to prevent the potentiation observed in Mn/LPS exposed cells
(Filipov et al., 2005).
Significance of research and hypothesis
In previous research, we have demonstrated that Mn-potentiated, LPS-induced
inflammatory cytokine production by N9 microglia is NF-κB-dependent (Filipov et al.,
2005). At present, it is not known whether the potentiation of inflammatory cytokines
and NO production by Mn occurs at the level of NF-kB or further upstream in the
intracellular signaling cascade. Since potential ‘upstream’ targets include the MAPK
family of kinases, it is reasonable to suggest that Mn may act on one, or more, of the
MAPK. Moreover, as the MAP2K are responsible for activating the MAPK, while
phosphatases (i.e. DUSP) deactivate MAPK, it is necessary to examine the role of these
molecules in the potential activation of the MAPK by Mn exposure. Furthermore, as
TLR intracellular signaling is differential, examining Mn-potentiation of microglial
output of inflammatory mediators in N9 microglia activated by different TLR may
provide additional data regarding the mechanism of Mn-potentiation. We hypothesize (i)
that Mn enhances inflammatory cytokine production by acting on one or more of the
MAPK molecules, leading to increased phosphorylation and prolonged activation of the
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MAPK, (ii) if enhanced MAPK activation is observed, either increased MAP2K
activation or decreased phosphatase activity may be involved, and (iii) enhanced MAPK
activation may not be specific to TLR4 activation, as Mn may potentiate inflammatory
cytokine production in microglia activated by other TLR.
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CHAPTER II
MANGANESE POTENTIATION OF IN VITRO PROFINFLAMMATORY CYTOKINE
PRODUCTION BY ACTIVATED MICROGLIAL CELLS IS ASSOCIATED WITH
PERSISTENT ACTIVATION OF P38 MAPK1
Abstract
Previous studies that investigated the role of inflammation in the neurotoxicity of
manganese (Mn) found that Mn enhanced the production of inflammogen
(lipopolysaccharide; LPS)-induced inflammatory cytokines such as IL-6 and TNF-α.
Although we have shown that the enhanced cytokine production occurs via a NF-κBdependent mechanism, the role of upstream kinases in this Mn-induced enhancement has
not been explored. As other studies have demonstrated that p38 mitogen activated
protein kinase (p38) is necessary for LPS-induced, NF-κB-dependent expression of
inflammatory cytokines, we hypothesized that Mn enhancement of LPS-induced
production of IL-6 and TNF-α may be associated with p38 and conducted a series of
experiments to address our hypothesis. We found that pre-treatment of microglial cells
with a p38-inhibitor (SB203580) prevented Mn+LPS- induced production of IL-6 and

1

Reprint with permission (Appendix A) from Crittenden, P. L., and Filipov, N. M. (2008).

Manganese-induced potentiation of in vitro proinflammatory cytokine production by
activated microglial cells is associated with persistent activation of p38 MAPK. Toxicol
In Vitro 22, 18-27.
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TNF-α. Moreover, potentiation of IL-6 and TNF-α production, which occurred in both
concurrent and sequential (3 h apart) exposures to Mn and LPS, was inhibited by
inhibition of p38. Additionally, Mn exposure enhanced the phosphorylation and activity
of p38 and this effect was persistent. Although p38 activity declined over time in vehicle
and LPS-exposed cells, it persisted in cells exposed to Mn or Mn+LPS. Thus, the
increased production of inflammatory cytokines by LPS-activated microglia exposed to
Mn is associated with increased and persistent activation of p38.
Introduction
Manganese (Mn), while an essential metal, is also a common environmental
contaminant. The presence of Mn in alloys, fertilizers, batteries, and fungicides, as well
as the re-introduction of the fuel additive methylcyclopentdienyl manganese tricarbonyl
(MMT), is of environmental and occupational concern (Frumkin and Solomon, 1997;
Aschner, 2000). Occupational exposure to Mn has been linked to a specific
neuropathology, manganism, that is characterized by clinical signs and lesions similar to
Parkinson’s Disease (PD; Meco et al., 1994). Manganese is thought to exert its effects, at
least partially, by disrupting mitochondrial respiration leading to increased oxidative
stress (Aschner and Aschner, 1991; Gavin et al., 1999). This is supported by studies
demonstrating that Mn-containing compounds, such as the fungicide Maneb and the fuel
additive MMT, can inhibit mitochondrial respiration (Autissier et al., 1977; Zhang et al.,
2003).
While Mn is directly toxic to neuronal cells, neurons are not the only CNS cells
that are associated with and contribute to Mn neurotoxicity. Astrocytes, for example,
18

accumulate Mn and may produce reactive oxygen species (ROS) and other substances
that may be damaging to neurons (Aschner, 2000). Importantly, it has been demonstrated
that the other CNS resident cells, the microglia, and/or the astrocytes may produce
inflammatory mediators that could be involved in the mechanisms of Mn neurotoxicity,
especially in cases where an additional inflammatory stimulus is present (Spranger et al.,
1998; Chang and Liu, 1999; Filipov et al., 2005).
Microglia have been implicated in PD (humans and animal models) and research
utilizing the model PD toxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
has shown that activated microglia persist long after exposure to MPTP has ended
(McGeer et al., 1987; McGeer et al., 2003). Additionally, it has been demonstrated that
prior exposure to Mn before challenge with MPTP will result in greater basal ganglia
pathology than exposure to Mn or MPTP alone (Takahashi et al., 1989). Therefore, this
study suggests that Mn exposure has the potential of interacting with other basal ganglia
toxicants, thus causing greater neurotoxicity. However, the likelihood of such exposure
(i.e. Mn + MPTP) is remote. A more relevant model, however, may involve Mn and
lipopolysaccharide (LPS). LPS is a common environmental contaminant (Niehaus and
Lange, 2003) and model inflammogen due to its ability to stimulate microglia to produce
cytokines, nitric oxide (NO), and ROS (Chao et al., 1992; Jeohn et al., 2002b; Liu et al.,
2002). Importantly, LPS exposure is also associated with basal ganglia toxicity (Niehaus
and Lange, 2003) and it has been used as a model for PD (Castano et al., 2002; Liu et al.,
2002)
Binding of LPS to CD14 and TLR4 cell surface receptors leads to the activation
of intracellular kinases, including the mitogen activated protein kinases (MAPK; Bhat et
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al., 1998; Jeohn et al., 2002b). The MAPK family of proteins is comprised of the
extracellular signal-regulated kinases (ERK), stress-activated or c-Jun N-terminal kinases
(SAPK/JNK), big MAPK 1 (BMK1), and the p38 MAPK (Koistinaho and Koistinaho,
2002). Of these MAPK, p38 MAPK (p38) and ERK appear to be primarily involved in
the production of inflammatory mediators by microglia. In primary microglia and
microglial cell lines, LPS has been shown to dose- and time-dependently increase the
phosphorylation of ERK and p38, as well as increase the expression of iNOS and TNF-α
(Lee et al., 1993; Lee et al., 1994; Bhat et al., 1998). However, the p38-dependent
increases in NO production require not only the phosphorylation of p38 but increased
kinase activity as well (Jeohn et al., 2002a). Additionally, by exposing microglia to ERKand p38-inhibitors prior to exposure to LPS, the LPS-induced increases in NO and TNFα were inhibited (Bhat et al., 1998). Furthermore, LPS-induced, p38-dependent,
increases in NO and TNF-α by microglia have been shown to decrease neuronal
survivability in neuronal-glial co-culture (Jeohn et al., 2002a; Jeohn et al., 2002b). The
fact that this effect can be inhibited by pretreatment with inhibitors of p38 suggests that
p38 appears to play a dominant role in the process.
Although inflammatory responses are essential for the maintenance and defense
of tissues, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis,
especially in sensitive tissues like the nervous system. In fact, abnormally high levels of
inflammatory cytokines, such as TNF-α, have been implicated in the etiology of PD
(Nagatsu et al., 2000). Within the context of Mn neurotoxicity, Mn enhances the
production of inflammatory mediators by microglia. Indeed, exposure to Mn potentiates
LPS-induced production of inflammatory cytokines (TNF-α & IL-6) and NO in vitro
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(Filipov et al., 2005). Additionally, this effect is NF-kB-dependent as inhibitors of NF-kB
were able to prevent the potentiation observed in Mn+LPS exposed cells (Filipov et al.,
2005). At present, it is not known whether the potentiation of inflammatory cytokine
production by Mn occurs at the level of NF-kB or further upstream in the intracellular
signaling cascade. Since potential upstream targets include p38 and ERK and because a
p38 inhibitor alone or in combination with an ERK inhibitor prevents the LPS-induced
production of inflammatory mediators (Bhat et al., 1998), we conducted preliminary
studies examining the effect of MAPK inhibition on cytokine production in Mn-exposed
microglial cells activated with LPS (Crittenden and Filipov, 2004). From these studies
we determined that inhibition of p38, but not of ERK, eliminated the potentiation of LPSinduced cytokine production in N9 microglial cells.
After we established the role of p38 in the enhancement of LPS-induced
inflammatory cytokine production by Mn, our objectives in this study were to (i) examine
in detail the functional activation of p38 by exposure to Mn by itself or in combination
with LPS (ii) to evaluate the time-window during the inflammatory cytokine production
process which is dependent upon p38 in Mn+LPS-exposed microglia.
Materials and Methods
Chemicals. Unless specified, all chemicals and reagents were purchased from
Sigma-Aldrich (Sigma; St. Louis, MO) and MnCl2 with purity >99% was used.
Cell Culture. The N9 murine microglial cell line used in the experiments was a
gift kindly provided by Dr. P. Ricciardi-Castagnoli (University of Milan, Italy). These
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cells, derived by a retroviral immortalization of day-13 embryonic mouse brain cultures,
are similar to primary microglia in that, upon activation, they produce inflammatory
cytokines, such as IL-1β, IL-6, and TNF-α, as well as NO (Righi et al., 1989).
The cultures were maintained (5% CO2, 95% air, at 37°C) in RPMI-1640
supplemented with 10% FBS, 0.075% sodium bicarbonate, 1 mM sodium pyruvate, 1
mM non-essential amino acids, 2 mM L-glutamine, 50 µM 2-mercaptoethanol, 25 µg/ml
gentamycin, 100 U/ml penicillin G, and 100 mg/ml streptomycin (all from Invitrogen,
Carlsbad, CA). For pharmacological inhibition and cytokine studies, cells were seeded at
0.25 x 106 cells/well (0.5 ml volume) in 48-well plates (Costar; Fisher Scientific,
Pittsburgh, PA). For western blot protein analysis, cells were seeded at 2.5 x 106
cells/well (5 ml volume) in 6-well plates (Costar), whereas for the flow cytometry
analysis, the density was 2.0 x 106 cells/well (4 ml volume). Cells were incubated for up
to 24 h in the presence of Mn (250 µM) and/or LPS (Escherichia coli 055:B5;
Calbiochem, La Jolla, CA; 100 ng/ml).
In our preliminary studies (Crittenden and Filipov, 2004), and in Filipov et al.,
(2005), Mn concentrations of 50-1000 µM and LPS of 10-1000 ng/ml were used, and the
potentiation of cytokine production was both Mn- and LPS-dependent. Hence, the
concentrations of Mn and LPS used in this study were selected based on previous
experiments that indicated no significant N9 cell death following exposure to Mn and/or
LPS at these concentrations (Filipov et al., 2005) and are in line with numerous other in
vitro studies where levels of Mn (Mn2+) range from 10 µM to 4 mM with the most typical
exposure range being 100 to 500 µM (Li et al., 2005; Malthankar et al., 2004).
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Moreover, the above concentrations and the concentrations used in our study are
representative of Mn levels found in brains of non-human primates following exposure to
manganese dioxide for 3 months (ranging from 35 to 350 µM; Suzuki et al., 1975).
Elevated levels of Mn in the basal ganglia are not associated only with occupational
exposure, but have been also observed in the brains of PD patients, as well as in
autopsied brains of patients with cirrhosis (Yase, 1972). Of note, the concentration of
LPS we have used in the present study (100 ng/ml) is relatively low and we have already
reported that when greater amounts of LPS are present in the culture medium, less Mn is
required for a potentiating effect on cytokine production to be observed (Filipov et al.,
2005).
Cytokine Analysis. The amounts of interleukin-6 (IL-6) and tumor necrosis
factor-α (TNF-α) in the supernatants were determined using DuoSet ELISA kits (R&D;
Systems, Inc., Minneapolis, MN) as per manufacturer’s instructions. Briefly, 96-well
microplates (Costar) were coated with 1:180 dilution of respective capture antibody in
PBS and incubated overnight at room temperature (RT). The plates were then washed
with PBS-Tween buffer (3x) and blocked (1% BSA, 5% sucrose in PBS) for 1 h at RT.
Next, plates were washed again (3x) and either samples or standards were dispensed into
the wells. After incubating for 2 h at RT the plates were washed (3x), incubated with
detection antibody for 2 h, and washed again (3x). Strepavidin-HRP conjugate was then
added for 20 min, plates were washed (3x), and TMB-based substrate was added to each
well and allowed to develop up to 30 min. The reaction was stopped by addition of 50 µl
of 2N H2SO4 per well and the absorbance was read using a Spectramax Plate Reader
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(Molecular Devices, Sunnyvale, CA) at 450 nm. All samples for each cytokine were
assayed in duplicate, and the mean was used in the subsequent statistical analysis. A
standard curve was generated for each plate.
Pharmacological manipulations. The p38 inhibitor, SB203580 (Calbiochem,
San Diego, CA), was added 3 h prior to, or after, the addition of Mn, LPS, or Mn and
LPS to the cell culture. The inhibitor was dissolved in DMSO (26.5 mM) and stored at –
80°C until diluted to a working concentration (50 µM) prior to use. The final DMSO
concentration was < 0.2% for vehicle and p38-inhibitor exposed cells.
Immunoblot analysis of p38 and phospho-p38. After incubation for 15 min, 1
and 4 h, cells were removed from the culture well via scraping and the cell suspension
was centrifuged (300g; 10 min; 4°C). Following centrifugation, the supernatants were
discarded, cells were resuspended in 100µl of RIPA (modified radioimmunoprecipitation) lysis buffer (1x PBS, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS)
containing PMSF (Sigma), protease and phosphatase inhibitors (Protease Inhibitor
Cocktail, Sigma, and Halt Phosphatase Inhibitor Cocktail, Pierce [Rockford, IL],
respectively), and held on ice for 30 min with occasional pipetting to disrupt cell
membranes. Protein concentration in the cell lysates was determined using the Bradford
method with reagents obtained from Bio-Rad (Hercules, CA) with BSA as a standard.
Aliquots of each sample were diluted in reducing sample buffer and heat denatured for 5
min at 95 ºC. Twenty micrograms of total protein were loaded and separated on a 10%
SDS-PAGE gel, transferred to a PVDF membrane, and the membranes were blocked in
5% milk for 1 h at RT. The membranes were then incubated overnight with rabbit
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antibodies specific for the non-phosphorylated or phosphorylated p38 (Cell Signaling
Technology, Beverly, MA) at 1:1000 and 1:500 dilutions, respectively, washed 3x, and
then probed with goat anti-rabbit secondary antibody conjugated with horseradish
peroxidase (Bio-Rad) at a 1:10,000 dilution. The blots were exposed to SuperSignal
West Pico chemiluminescent substrate (Pierce) for up to 5 min and then enclosed in
transparent covers prior to exposure to x-ray film. Band density was analyzed using the
UN-SCAN-IT software package (Silk Scientific Inc., Orem, UH).
Phospho-p38 analysis by flow cytometry. Four ml of 0.5 x 106 cells/ml N9 cell
suspension (2 x106 cells/well) were plated overnight in 6-well plates as described above.
Cells were incubated with Mn/LPS for 15 min, 1, and 4 h. Following incubation, cells
were lifted from the culture wells with a cell lifter, spun down (10 min; 300 xg; 4 ºC),
and resuspended in 0.5 ml of PBS. Cells were then fixed by adding of 0.5 ml of 4%
paraformaldehyde (2% final concentration) to the tubes and incubating them for 10 min
at 37ºC. Next, the cells were chilled for 1 min on ice, centrifuged (10 min; 300 xg; 4 ºC),
and permeabilized by resuspending them in 1 ml of 90% methanol and an incubation for
30 min on ice, followed by an overnight incubation at -20 ºC. The next day, cells were
centrifuged to remove the methanol and washed twice with a binding buffer (1% BSA in
PBS, 2 ml for each wash). Next, 1 ml of the cell suspension (approximately 0.6 x 106
cells) was transferred to flow tubes, spun down, and resuspended in 100 µl of binding
buffer. Following 10 min incubation at RT, 10 µl/tube of the anti-phospho-p38
(T180/Y182)-PE pre-titrated antibody, or an appropriate PE-conjugated isotype control
(mouse IgG1; both from BD Biosciences, San Diego, CA) were added and the tubes
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incubated for 60 min at RT in the dark. At the end of this incubation, the cells were
washed twice with a binding buffer, resuspended in 0.5 ml of PBS and analyzed by
FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA).
p38 activity analysis. The enzymatic activity of the phosphorylated p38 was
determined by a western blot analysis using the p38 MAP Kinase Assay Kit (Cell
Signaling Technology). Briefly, following exposure to Mn and/or LPS the cells were
rinsed once with ice-cold PBS followed by incubation with 0.5 ml of ice-cold 1x lysis
buffer containing 1mM PMSF for 5 min. Cells were scraped and transferred to 1.5 ml
tubes, sonicated 4x for 5 sec, and centrifuged (14,000 x g) for 10 min at 4 ºC. Next, 20 µl
of bead-immobilized antibody slurry was added to 200 µl of sample supernatant and
incubated overnight at 4 ºC. After centrifugation (14,000 x g) for 10 min at 4 ºC), the
samples were washed (2x) in 1x lysis buffer followed by 2 washes in 1x kinase buffer.
Finally, each sample was resuspended in 50 µl of 1x kinase buffer supplemented with
200 µM ATP and 2 µg of kinase substrate (ATF-2 fusion protein). All samples were
incubated for 30 min at 30 ºC. The kinase reaction was terminated by denaturing at 95
°C for 5 min in 3x SDS sample buffer containing 150 mM DTT. The samples were
electrophoretically separated (10% SDS-PAGE gel) and transferred to PVDF membranes.
The membranes were blocked in 5% w/v nonfat milk and probed with a polyclonal,
rabbit IgG anti-Phospho-ATF-2 (Thr71) antibody at a 1:2000 dilution. Following
washing (3X), the membranes were incubated with HRP-conjugated anti-rabbit IgG and
HRP-conjugated anti-biotin antibody (for biotinylated protein molecular weight markers).
The membranes were incubated for 1 min in LumiGLO substrate and wrapped in sheet
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protectors. The membranes were exposed to X-ray film for 10 s, the films developed and
band density analyzed using the UN-SCAN-IT software package.
Statistical analysis. Data were analyzed using analysis of variance (ANOVA).
When statistical differences were detected (P < 0.05), treatment means were separated by
the Student Newman Keuls (SNK) post hoc test. All data are presented as means +
S.E.M.
Results
Pharmacological manipulation. To determine the time-dependency in the ability
of Mn to enhance LPS-induced pro-inflammatory cytokine production and its association
with p38, in addition to exposing cells to Mn+LPS as before (Filipov et al., 2005), we
exposed cells to 250 µM Mn 3 h before or after activation by 100 ng/ml LPS. As
previously observed, exposure to Mn+LPS potentiated the microglial production of TNFα (Figure 2.1A) and IL-6 (Figure 2.1B). Cells activated with LPS 3 h before or after
exposure to 250 µM Mn produced more TNF-α (Figure 2.1A) and IL-6 (Figure 2.1B) in
comparison to LPS-alone. In terms of the timing of exposure to Mn or LPS, the observed
potentiation effect was the lowest when Mn was added 3 h after LPS, but, nevertheless,
the potentiation was still present.
Exposure to 250 µM Mn and 50 µM SB203580 3 h after LPS activation prevented
Mn-induced potentiation of TNF-α and IL-6 (Figures 2.1A and 2.1B). Similarly,
exposure to Mn followed by SB203580 and LPS 3 h later also prevented Mn-induced
potentiation of TNF-α and IL-6 (Figures 2.1A and 2.1B, respectively). Additionally,
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SB203580 inhibited cytokine production in cells exposed simultaneously to Mn+LPS,
regardless of whether Mn+LPS exposure occurred before, or after, SB203580 (Figures
2.1A and 2.1B).
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Effect of delayed exposure to Mn and/or SB203580 (a p38 inhibitor) on
LPS-activated microglial cytokine production.
TNF-α (1A) and IL-6 (1B) production was analyzed in supernatants
collected 24 h after exposure of N9 microglial cells to LPS (100 ng/ml) then
Vehicle (3 h later), Mn (250 µM) + LPS then Vehicle (3 h later), LPS then
Mn (3 h later), Mn then LPS (3 h later), LPS then SB203580 (3 h later), LPS
then Mn + SB203580 (50 µM), Mn then LPS + SB203580, Mn + LPS then
SB203580, and SB203580 then Mn + LPS. Media levels of TNF-α and IL6 were analyzed by respective DuoSet ELISA as described in the Materials
and Methods. Data shown in each bar represent the mean ± S.E.M. of 4-8
independent replicates. a, b, c, d Presence of different letters indicate bars are
significantly different from control and previous exposures (P < 0.05).
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Immunoblot analysis of p38 and phospho-p38 protein levels. To examine p38
activation, we studied the induction of p38 phosphorylation following exposure to Mn
(250 µM) with and without LPS (100 ng/ml) for up to four hours after exposure. The
levels of non-phosphorylated p38 (all exposures) did not change in response to Mn and/or
LPS exposure (data not shown). However, induction of p38 phosphorylation (normalized
to non-phosphorylated p38) was observed as early as 15 min following Mn and/or LPS
exposure (Figure 2.2A). Increased phosphorylation was observed at 1 h for Mn+LPS and
this effect persisted through the 4 h time point (Figures 2.2B and 2.2C, respectively). On
the other hand, the LPS-induced phosphorylation had almost returned to control levels,
while Mn-alone increased p38 phosphorylation at the 4 h time point (Figure 2.2C).
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Densitometric analysis (left panels) and representative western blots (right
panels) of phosphorylated p38 kinase in N9 microglia exposed to Mn, LPS,
or Mn+LPS.
(A) Phosphorylated p38 protein from N9 cells exposed to vehicle, 250 µM
Mn, 100 ng/ml LPS, or 250 µM Mn+100 ng/ml LPS for 15 min (A), 1 h (B)
and 4 h (C). Western blots and densitometric analyses were performed as
described in the Materials and Methods. Data shown in each bar represent
the mean ± S.E.M. of the adjusted pixel density for phosphorylated p38
normalized to non-phosphorylated p38. Each bar represents a minimum of
3 independent replicates. a Presence of letters indicate treatment differences
within a time point (P < 0.05).
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Phospho-p38 analysis by Flow Cytometry. Similar to the western blot data
(Figure 2.2), flow cytometry results indicated a time-dependent effect of LPS, Mn, and
Mn+LPS on phospho-p38 (Figure 2.3). Thus, in the absence of Mn, 100 ng/ml LPSinduced increase was rapid (15 min), but it plateaued at 1 h and begun to subside at the 4
h time point. On the other hand, 250 µM Mn increased the phospho-p38 levels by 15 min
in comparison with the effect being significant at the 1 and 4 h time points. While at 15
min the Mn+LPS combination increased phospho-p38 to an extent similar to LPS, at the
1 and 4 h time points, the Mn+LPS effects were greater than the effects of either Mn or
LPS alone. Importantly, similar to the western blot data, by 4 h the LPS-induced
phosphorylation had returned to near control levels.
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Figure 2.3 Phosphorylated p38 protein levels in N9 microglia exposed to 250 µM with
or without 100 ng/ml LPS.
Cells collected after 15 min, 1 h, or 4 h exposure were analyzed by flow
cytometry as described in the Materials and Methods. Data shown represent
the mean fluorescence intensity (MFI) change from the 15 min control ±
S.E.M. for two independent experiments where each experimental condition
was independently replicated (n =4). a, b Presence and different letters
indicate treatment differences within a time point (P < 0.05).
p38 activity. The kinase activity of p38 was measured using western blot detection of a
phosphorylated-substrate (ATF-2 Fusion Protein). Exposure to 250 µM Mn, 100 ng/ml
LPS, or Mn+LPS increased p38-kinase activity at 15 min and 4 h compared to control
(Figures 2.4A, and 2.4B). This effect persisted through the 4 h time point, but only for
the Mn and Mn+LPS exposed cells (Figure 2.4C).
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p38 activity following exposure to vehicle, 250 µM Mn and/or 100 ng/ml
LPS for 15 min (A), 1 h (B), or 4 h (C) in N9 microglia cells.
The p38 activity in whole cell lysates was analyzed by western blot for the
detection of a phosphorylated p38 substrate (ATF-2 Fusion Protein)
followed by densitometric analyses (left hand panel) as described in the
Materials and Methods. Blots representative of three independent
experiments are shown in the right hand panel. Data shown in each bar
the mean ± S.E.M. of the total pixel density for 3 independent replicates. a,b
Presence and different letters indicate treatment differences within a time
point (P < 0.05).
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Discussion
Although it has been demonstrated that microglia play a role in basal ganglia
neurotoxicity (Olanow and Tatton, 1999; Castano et al., 2002), how environmental
toxicants like Mn contribute to microglial-mediated inflammation has only recently been
explored. Brain regions that possess an abundance of microglial cells are especially
sensitive to inflammatory stimuli, particularly the bacterial endotoxin LPS (Kim and de
Vellis, 2005). Activation of macrophages and microglia by LPS is thought to occur
(primarily) by binding of LPS to TLR4, leading to activation of intracellular kinases (i.e.
MAPK) and transcription factors like NF-κB (Medzhitov and Janeway, 1997; Takeda and
Akira, 2004). Moreover, activation of the MAPK and NF-κB by LPS results in the
production of inflammatory mediators such as NO and TNF-α (Bhat et al., 1998; Lee et
al., 1993; Lee et al., 1994).
Previous research has demonstrated that Mn exposure, in combination with LPS,
can increase the production of iNOS and NO by microglial cells (Chang and Liu, 1999;
Filipov et al., 2005; Chen et al., 2006), as well as the production of the inflammatory
cytokines TNF-α (Filipov et al., 2005; Chen et al., 2006) and IL-6 (Filipov et al., 2005).
On its own, Mn exposure increases the cytokine production only slightly and at higher
concentrations, suggesting that microglial activation must be present in order for the Mn
effects on TNF-α and IL-6 to be observed. In this study, similar to Filipov et al., (2005),
we observed a strong potentiation of TNF-α and IL-6 production by N9 microglial cells
following exposure to Mn+LPS compared to exposure to LPS alone. Interestingly, Mnpotentiation of IL-6 in activated microglia was greater than for TNF-α, with IL-6
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concentrations increasing 5-fold or more, in comparison to 2-fold changes in TNF-α. On
the other hand, exposure to the p38 inhibitor SB203580 inhibited TNF-α in Mn+LPSexposed cells to a greater extent than the inhibition observed for IL-6, suggesting that
although both cytokines depend on p38 for their synthesis, the degree of dependency may
be different for the two cytokines
Importantly, we were also able to demonstrate that Mn can potentiate LPSinduced cytokine production if the Mn-exposure occurs 3 h after the exposure to the
inflammatory stimulus, or, alternatively, that prior (3 h) exposure to Mn can potentiate
the LPS-induced inflammatory cytokine production. To our knowledge, this is the first
report of this observation, providing additional data to support the hypothesis that Mn
exposure can potentiate the production of inflammatory cytokines in vitro and, possibly,
inflammation in vivo not only in cases of co-exposure to an inflammogen and Mn, but
also in cases where the exposure is, within a (possibly) narrow window, sequential.
LPS has been shown to activate the MAPK family of kinases, leading to the
production of inflammatory mediators such as NO and TNF-α (Bhat et al., 1998; Lee et
al., 1993; Lee et al., 1994). While for microglia, both p38 and ERK MAPK have been
shown to contribute to the production of inflammatory mediators (Bhat et al., 1998;
Jeohn et al., 2002a; Koistinaho and Koistinaho, 2002; Zarubin and Han, 2005), p38
appears to play a dominant role. For example, LPS-stimulated production of NO and
cytokines by microglia can be inhibited by prior exposure to a p38 inhibitor (Bhat et al.,
1998; Jeohn et al., 2002a). This is also the case with Mn potentiation of LPS-induced
cytokine expression in the present study, as exposure to SB203580 before or after
exposure to Mn+LPS inhibited the production of IL-6 and TNF-α by N9 microglial cells.
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In support, our western blot and flow cytometry p38 activity data indicated that the
increased p38 activity caused by Mn persists for at least 4 h.
In contrast, the ERK inhibitor (PD98059) has a very small effect on IL-6 and
TNF-α production by the Mn+LPS exposed microglia (Crittenden, 2004; data not
shown), suggesting that activation of other MAPK which are known to contribute to the
production of inflammatory mediators in microglia (Bhat et al., 1998; Koistinaho and
Koistinaho, 2002; Zarubin and Han, 2005), play only a minor role in the Mn+LPSinduced production of TNF-α and IL-6.
Two other recent studies have investigated the role of intracellular kinases in the
Mn effects on NO/iNOS and/or TNF-α production using the microglial cell line BV-2
(Bae et al., 2006) or primary mixed glial cells (Chen et al., 2006). Bae et al. (2006)
examined the effects of Mn (100 µM to 1 mM) by itself only on iNOS and suggested that
multiple MAP kinases were phosphorylated by Mn and that, based on inhibitor data, the
p38 kinase appeared not to play a major role in the Mn-induced iNOS. Nevertheless, even
though not quantified, these authors did report that p38 phosphorylation was increased by
Mn at 1, 3 and 6 h post exposure, thus agreeing with our data. In their studies with
primary glial cells, which contain both astrocytes and microglia (85 and 15% ,
respectively), Chen et al. (2006) observed that (i) the phosphorylation of multiple (p38,
ERK, JNK) kinases was induced by 30 min exposure to Mn, either by itself or in
combination with LPS/IFN-γ, (ii) similar to our present data and to Filipov et al. (2005),
while having no effect on its own, Mn potentiated TNF-α production by glial cells
exposed to LPS/IFN-γ, and (iii) pharmacological inhibition of p38 was one of the ways of
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inhibiting the potentiating effect of Mn on TNF-α production. Interestingly, these authors
also suggested that iNOS/NO production may be regulated in a manner different from
that of TNF-α. Importantly, similar to our present studies, Chen et al. (2006) indicated
that an activation of MAPKs by Mn is not sufficient to trigger the glial cell production of
TNF-α, but that it is critical for the potentiating effects of Mn on LPS/IFN-γ -stimulated
TNF-α production to be observed.
Having observed that p38 was required for the Mn-potentiation of cytokine
production, it was necessary to examine p38 phosphorylation directly as enhanced
phosphorylation is associated with increased activity and thus could increase the
production of IL-6 and TNF-α. Indeed, this observation was supported by western blot
analysis and flow cytometry. Although LPS did increase the phosphorylation of p38
through the 1 h time point, by 4 h this effect had diminished. In contrast, prolonged
phosphorylation of p38 was observed in Mn-exposed cells, persisting through the 4 h
time point.

In comparison, increased p38 activation was observed in Mn-exposed cells,

an effect that persisted through the 4 h time point. LPS alone increased p38 activity,
however by 4 h the LPS-induced increase in p38 activity had largely subsided.
Moreover, we have observed enhanced p38 activation 24 h following exposure to Mn or
Mn+LPS (data not shown).
While p38 is clearly associated with the Mn-potentiation of TNF-α and IL-6 by
activated microglia, how Mn enhances the phosphorylation and activity of p38 is not
apparent at this time. One possibility is that Mn acts at a site other than p38, perhaps
upstream at the level of the MAPK kinase (MKK). The MKKs are responsible for
phosphorylating MAPK to its active form. Two MKK that are known to activate p38 are
38

MKK3 and MKK6 (Koistinaho and Koistinaho, 2002; Zarubin and Han, 2005).
Increased activity by MKK3 or MKK6 could lead to enhanced p38 MAPK activation
(Enslen et al., 1998). Alternatively, inhibition of the enzymes responsible for
inactivating p38, the dual specificity phosphatases (DUSP; Groom et al., 1996), may be
responsible for the prolonged phosphorylation following exposure to Mn/LPS that was
observed in the current study. In this regard, another metal, arsenic, has been shown to
inhibit a different DUSP responsible for maintaining low basal levels of JNK (Cavigelli
et al., 1996). Additionally, it has been demonstrated that ERK can negatively regulate
p38 via the MAPK phosphatase MKP-1 (Carter et al., 1999). It is possible that Mn
inhibits either ERK-mediated activation of MKP-1 or, MKP-1 activity.
Our earlier study indicated that the Mn-induced potentiation of IL-6 and TNF-α is
NF-κB dependent (Filipov et al., 2005). With our present study we demonstrate that p38
is critical for the Mn-induced potentiation of cytokine production to occur. Exactly how
NF-κB and p38 are interacting in Mn+LPS exposed microglia is the subject of future
studies. A possible mechanism involves NF-κB and regulation of gene transcription.
Active p38 phosphorylates the TATA-binding protein (TBP), resulting in the association
of TBP with the TATA-promoter as it has already been demonstrated that p38
phosphorylation of TBP is required for NF-κB-dependent gene expression, including
TNF-α and IL-6 (Carter et al., 1999). As Mn-potentiation of LPS-induced inflammatory
cytokine production appears to require both p38 and NF-κB, it is possible that the
observed increases in p38 activity may increase phosphorylation of TBP leading to
enhanced NF-κB-dependent gene expression of IL-6, TNF-α and, possibly, other
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inflammatory mediators. This is further supported by the observation in the present study
that increased phosphorylation of p38 was observed in cells exposed to Mn in the absence
of LPS. However, Mn exposure alone resulted in negligible amounts of IL-6 and TNF-α
produced by the N9 microglia as demonstrated in our previous study (Filipov et al.,
2005). As synthesis of IL-6 and TNF-α is NF-κB-dependent, and exposure to LPS leads
to activation of NF-κB, it is likely that Mn-potentiation of inflammatory cytokine
production occurs via a p38-dependent mechanism, but requires the
subsequent/concurrent activation of NF-κB. Considering the interactive nature of
intracellular signaling, it is possible that Mn may be acting at multiple sites leading to
increased p38 phosphorylation and activity and subsequent IL-6 and TNF-α production
as proposed in Figure 2.5.
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Figure 2.5

Diagram of potential/known Mn sites of action in microglial intracellular
signaling following activation with LPS.
Small arrows indicate known intracellular signaling pathways while larger
arrows indicate possible sites of interaction between signaling molecules
and Mn. Large arrows with a ‘?’ denote potential sites of action for Mnenhanced p38 activity. Abbreviations: LPS (Lipopolysaccharide), LBP
(LPS Binding Protein), TLR4 (Toll Like Receptor 4), MKK3/6 (Mitogen
Activated Protein Kinase Kinase) p38 (p38 Mitogen Activated Protein
Kinase), p38-p (phosphorylated p38), ERK (Extracellular Signal-Regulated
Kinase), MKP-1 (Mitogen-activated protein kinase phosphatase-1), IkB
(Inhibitor of NF-kB), NF-kB (Nuclear Factor kappa B), TBP (TATABinding Protein), TATA (TATA Box).
41

In summary, enhanced production of inflammatory cytokines by microglia
exposed to Mn/LPS is associated with persistent activation of p38 and inhibition of p38
prevents this enhancement. Importantly, the increase cytokine production by Mn+LPS
occurs regardless whether the exposure to Mn and LPS is concurrent or sequential (3 h
apart); in all cases, the potentiation is prevented by inhibition of p38. Overall, our data
suggest that exposure to environmental toxicants, such as Mn, may prolong microglial
activation by utilizing the p38 pathway and contribute to chronic inflammation and
neurotoxicity.
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CHAPTER III
INCREASED P38 KINASE IN ACTIVATED MICROGLIA EXPOSED TO
MANGANESE IS ASSOCIATED WITH DECREASED EXPRESSION
OF THE PHOSPHATASE MKP-1 AND INCREASED
PHOSPHORYLATION OF THE MKK-1
AND -4 KINASES
Abstract
In previous work we have demonstrated that manganese (Mn) exposure
potentiates inflammogen (lipopolysaccharide; LPS)-induced inflammatory cytokine (e.g.
IL-6 and TNF-α) production by microglial cells and that this potentiation is associated
with enhanced and sustained p38 mitogen activated protein kinase (p38) activity. To
explain the enhanced p38 activity, we hypothesized that Mn either augmented the activity
of the kinases upstream of p38 (i.e. MKK-3/6, MKK-1/2, and/or MKK-4) or decreased
activity of the major phosphatase responsible for p38 inactivation, MKP-1 (mitogen
activated protein kinase phosphatase-1). We examined MKK activity following 1 or 4 h
exposure to Mn (250 µM), LPS (100 ng/ml), or Mn+LPS and observed that Mn in
combination with LPS increased phosphorylation of all three MKKs at 1 h, and MKK-3/6
at 4 h. However, for MKK-3/6, the observed activation by Mn+LPS was not different
from the phosphorylation caused by LPS alone; indicating that the enhanced p38 activity
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in the presence of Mn was not due to increased MKK-3/6 activation. In contrast to the
lack of effect of Mn on MKK-3/6, Mn+LPS exposure increased the phosphorylation of
MKK-1/2 and -4 at 1 h more than exposure to LPS alone, suggesting that effects of
Mn+LPS on MKK-1/2 and -4 may lead to the previously observed enhanced p38 activity.
Next, we examined the negative regulator of p38, MKP-1, by western blot and
quantitative PCR. Exposure to Mn alone or in combination with LPS (1 h) decreased
both mRNA levels and the protein expression of MKP-1 relative to the MKP-1 levels in
control and LPS-exposed cells, respectively. Additionally, to correlate the sustained
increase of p38 by Mn+LPS with the increased inflammatory mediator production (i.e.
cytokines and prostaglandins), we performed a time-course mRNA study. Compared to
the effects of LPS alone, further increase in TNF-α mRNA expression by Mn+LPS was
observed as early as 1 h, while Mn+LPS markedly increased TNF-α, IL-6, and Cox-2
mRNA at 4 h, a time point coinciding with increased p38 activity. Thus, it appears that
the enhanced and sustained p38 activity and, at least in part, inflammatory mediator
expression by activated microglia exposed to Mn, may be due to decreased MKP-1 as
well as enhanced MKK-1/2 and -4 activities.

Introduction
Manganese (Mn) is an essential metal and a common environmental contaminant.
Besides mining operations, Mn is found in alloys, fertilizers, batteries, certain fungicides,
and as a component of the fuel additive methylcyclopentdienyl manganese tricarbonyl
(MMT; Frumkin and Solomon, 1997; Aschner, 2000). Excessive exposure to Mn is of
human health concern, since occupational exposure to Mn is linked to a specific
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neuropathology, manganism, that is characterized by clinical signs and lesions similar to
Parkinson’s Disease (PD; Calne et al., 1994; Meco et al., 1994; Frumkin and Solomon,
1997; Aschner, 2000; Huang et al., 2007). Although Mn is thought to exert its effects, at
least partially, by disrupting neuronal mitochondrial respiration, leading to increased
oxidative stress and cell death (Gavin et al., 1999), it has also been shown that Mn can
potentiate the production of inflammatory mediators by non-neuronal cells resident in the
CNS (Spranger et al., 1998; Chang and Liu, 1999; Barhoumi et al., 2004; Filipov et al.,
2005; Chen et al., 2006; Crittenden and Filipov, 2008).
Inflammatory responses are essential for the maintenance and defense of tissues.
However, uncontrolled or chronic inflammation can be detrimental to tissue homeostasis,
especially in sensitive tissues such as the nervous system (Perry et al., 1998). In fact,
abnormally high levels of inflammatory cytokines, e.g. TNF-α, have been implicated in
the etiology of PD (Nagatsu et al., 2000). For example, astrocytes accumulate Mn and
may produce reactive oxygen species (ROS) and other substances that may be damaging
to neurons (Aschner, 2000). Importantly, it has been demonstrated that microglia, the
resident brain macrophage, and/or astrocytes may produce inflammatory mediators that
could be involved in the mechanisms of Mn neurotoxicity, especially in cases where an
additional inflammatory stimulus such as lipopolysaccharide (LPS) is present (Spranger
et al., 1998; Chang and Liu, 1999; Filipov et al., 2005; Crittenden and Filipov, 2008).
LPS is a known environmental contaminant (Niehaus and Lange, 2003) and model
inflammogen due to its ability to stimulate inflammatory cells (microglia/macrophages)
to produce cytokines, nitric oxide (NO), and ROS (Chao et al., 1992; Jeohn et al., 2002b;
Liu et al., 2002).
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Binding of LPS to CD14 and TLR4 cell surface receptors leads to the activation
of intracellular kinases, including the mitogen activated protein kinases (MAPK; Bhat et
al., 1998; Jeohn et al., 2002b). The MAPK family of proteins is comprised of a series of
kinases, beginning with the MAP kinase kinase kinases (i.e. TAK1) that phosphorylate
MAP kinase kinase (i.e. MKK-1, -2, -3, -4, -6), which subsequently phosphorylate
MAPK. This MAPK cascade culminates in the activation of one or more MAPK,
including the extracellular signal-regulated kinases (ERK), stress-activated or c-Jun Nterminal kinases (SAPK/JNK), and the p38 MAPK (Koistinaho and Koistinaho, 2002).
Of these MAPKs, p38 MAPK (p38) and ERK appear to be primarily involved in the
production of inflammatory mediators by microglia (Koistinaho and Koistinaho, 2002).
MAPK deactivation is dependent on the actions of dual specificity phosphatases (DUSP),
primarily MAP kinase phosphatase-1 (MKP-1; Koistinaho and Koistinaho, 2002; Lang et
al., 2006; Wang and Liu, 2007).
In primary microglia and microglial cell lines, LPS has been shown to increase
the phosphorylation of ERK and p38, as well as increase the expression of iNOS and
TNF-α in a time- and dose-dependent manner (Lee et al., 1993; Lee et al., 1994; Bhat et
al., 1998). Of note, LPS-induced, p38-dependent, increases in NO and TNF-α by
microglia have been shown to decrease neuronal survivability in neuronal-glial co-culture
(Jeohn et al., 2002a). The fact that this effect can be inhibited by pretreatment with
inhibitors of p38 suggests that p38 plays a dominant role in the process (Bhat et al., 1998;
Jeohn et al., 2002b).
Within the context of Mn neurotoxicity, Mn enhances the production of
inflammatory mediators by microglia. Indeed, exposure to Mn potentiates LPS-induced
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production of inflammatory cytokines (TNF-α & IL-6) and NO in vitro (Filipov et al.,
2005; Crittenden and Filipov, 2008). In addition, Mn also potentiates Cox-2 expression
and ensuing prostaglandin production by inflammogen-activated mixed glial cells (Liao
et al., 2007). Potentiating effect of Mn on TNF-α and IL-6 involves the activation of NFkB and p38, as inhibitors of NF-kB and p38 were able to prevent the potentiation
observed in Mn+LPS exposed cells (Filipov et al., 2005; Crittenden and Filipov, 2008).
Furthermore, the p38-mediated effect is independent of the timing of exposure to Mn, as
Mn exposure 3 h before or after LPS, potentiated inflammatory cytokine production
(Crittenden and Filipov, 2008). Whether the potentiating effects of Mn on cytokine
production (and other inflammatory molecules) is at the level of transcription, and the
temporal relationship with p38, is unknown is present.
Additionally, p38-phosphorylation alone did not explain the enhanced production
of TNF-α and IL-6 in the presence of Mn+LPS, as LPS by itself increased the
phosphorylation of p38 at earlier time points (up to 1 h) to levels comparable to the
effects of Mn+LPS (Crittenden and Filipov, 2008). However, Mn+LPS exposure not
only increased p38 activity, but also prolonged it up to 4 h following the initial exposure,
a time point at which the LPS-increased p38 activity had subsided (Crittenden and
Filipov, 2008).
The mechanism of prolonged p38 activation in the presence of Mn is not
understood. It may be that Mn enhances, or prolongs, the activation of the MKKs
responsible for the activation of p38, primarily MKK-3/6 (Enslen et al., 1998). However,
MKK-1/2 (Meja et al., 2000) and MKK-4 (Derijard et al., 1995) may also activate p38.
Alternatively, decreased expression of MKP-1, the DUSP responsible for
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dephosphorylating p38, may lead to prolonged p38 activation (Hammer et al., 2005;
Lang et al., 2006; Wang and Liu, 2007).
To test these hypotheses, the major objectives of this study were to examine the
effects of Mn+LPS exposure on the MKKs responsible for activating p38 (e.g. MKK-3/6,
MKK-1/2, MKK-4) and on the major phosphatase responsible for deactivating p38,
MKP-1. We have previously reported that Mn potentiates TNF-α and IL-6 production by
LPS-activated microglia at the protein level (Filipov et al., 2005), and that this
potentiation is prevented by inhibition of p38 (Crittenden and Filipov, 2008). However,
nor we or others have determined whether the potentiative effect of Mn on cytokine
production occurs at the level of transcription. Therefore, an additional goal was to study
the time-course of the expression of certain inflammatory mediators (e.g. TNF-α, IL-6,
and Cox-2) in Mn+LPS-exposed microglia at the mRNA level, thus allowing us to
determine whether the potentiating effect of Mn is at the transcription level and whether
enhanced mRNA for TNF-α, IL-6, and Cox-2 by Mn+LPS coincides temporally with the
previously observed increased p38 activity.
Materials and Methods
Chemicals. Unless specified, all chemicals and reagents were purchased from
Sigma-Aldrich (Sigma; St. Louis, MO) and MnCl2 with purity >99% was used.
Cell Culture. The N9 mouse microglial cell line (Righi et al., 1989) was a gift
kindly provided by Dr. P. Ricciardi-Castagnoli (University of Milan, Italy) and is similar
to primary microglia and other cell lines, i.e. N13, in that it produces inflammatory
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cytokines, such as IL-1β, IL-6, and TNF-α, as well as NO when activated by
inflammogens such as LPS (Righi et al., 1989; Heyen et al., 2000). The cultures were
maintained (5% CO2, 95% air, at 37°C) in RPMI-1640 supplemented with 10% Hyclone
FBS (low endotoxin, ≤ 25 EU/ml; Hyclone, Logan, UT), 0.075% sodium bicarbonate, 1
mM sodium pyruvate, 1 mM non-essential amino acids, 2 mM L-glutamine, 50 µM 2mercaptoethanol, 25 µg/ml gentamycin, 100 U/ml penicillin G, and 100 mg/ml
streptomycin (all from Invitrogen, Carlsbad, CA). For real-time quantitative PCR
(qPCR) and western blot protein analysis, cells were seeded at 2.5 x 106 cells/well (5 ml
volume) in 6-well plates (Costar) and allowed to adhere overnight prior to exposure to
Mn or LPS. Cells were incubated for up to 4 h in the presence of Mn (250 µM) and/or
LPS (Escherichia coli 0111: B4; 100 ng/ml).
In previous studies (Filipov et al., 2005), Mn concentrations of 50-500 µM and
LPS amounts of 10-1000 ng/ml were used, and the potentiation of cytokine production
was both Mn- and LPS-dependent. Similar concentrations of Mn and LPS were used in
this study based on previous experiments that indicated no significant N9 cell death
following exposure to Mn and/or LPS at these concentrations (Filipov et al., 2005).
These observations are in line with numerous other in vitro studies where levels of Mn
(Mn2+) range from 10 µM to 4 mM with the most typical exposure range being 100 to
500 µM (Malthankar et al., 2004; Li et al., 2005). Moreover, the above concentrations
and the concentrations used in our study are representative of Mn levels found in brains
of non-human primates following exposure to manganese dioxide for 3 months (ranging
from 35 to 350 µM; Suzuki et al., 1975) and are in line with basal ganglia Mn levels
observed in the brains of PD patients (Yase, 1972), as well as in autopsied brains of
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patients with cirrhosis (Yase, 1972). Of note, the concentration of LPS we have used in
the present study (100 ng/ml) is relatively low and we have already reported that when
greater amounts of LPS are present in the culture medium, less Mn is required for a
potentiating effect on cytokine production to be observed (Filipov et al., 2005).
Dexamethasone (Dex) was used as a positive control for MKP-1, based on
published data showing induction of MKP-1 in the presence of Dex, as well as the
enhancement of LPS-induced expression of MKP-1 following exposure to both Dex+LPS
(Zhou et al., 2007).
Immunoblot analysis of MKK and MKP-1. After incubation for 1 and 4 h,
cells were removed from the culture wells via scraping and the cell suspensions were
centrifuged (300g; 10 min; 4°C). Following centrifugation, the supernatants were
discarded, cells were resuspended in 100µl of RIPA (modified radioimmunoprecipitation) lysis buffer (1x PBS, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS)
containing PMSF (Sigma), protease and phosphatase inhibitors (Protease Inhibitor
Cocktail, Sigma, and Halt Phosphatase Inhibitor Cocktail, Pierce [Rockford, IL],
respectively), and held on ice for 30 min with occasional pipetting to disrupt cell
membranes. Protein concentration in the cell lysates was determined using the Bradford
method with reagents obtained from Bio-Rad (Hercules, CA) and with bovine serum
albumin (BSA) as a standard. Aliquots of each sample were diluted in reducing sample
buffer and heat denatured for 5 min at 95 ºC. For gel electrophoresis, Kaleidoscope
Molecular Weight Standard (Bio-Rad; Hercules, CA) was included as a western blot
transfer control, while Magic Mark (Invitrogen; Carlsbad, CA) was used for molecular
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weight determination and transfer control on the x-ray film. Twenty micrograms of total
protein (MKK-3/6), 30 µg for MKK-1/2 and MKK-4, or 50 µg (MKP-1), was loaded and
separated on a 10% SDS-PAGE gel, transferred to a PVDF membrane, and the
membranes were blocked in 5% milk (MKK-3/6 and MKP-1) or fish gelatin (MKK-1/2
and MKK-4) for 1 h at RT. The membranes were then incubated overnight at 4ºC with
antibodies specific for the non-phosphorylated (1:1000) and phosphorylated (1:500)
MKK-3/6 (Cell Signaling Technology, Beverly, MA), phosphorylated (1:1000) MKK-1/2
and MKK-4 (Santa Cruz Biotechnology Inc, Santa Cruz, CA) and (1:500) MKP-1
protein (Santa Cruz). Following a wash (3x), the membranes were probed with either
goat anti-rabbit secondary antibody conjugated with horseradish peroxidase (1:10,000,
Bio-Rad) for MKK-3/6 and MKP-1, or rabbit anti-goat secondary antibody conjugated
with horseradish peroxidase (1:30,000, Santa Cruz) for MKK-1/2 and MKK-4. Next, the
blots were exposed to SuperSignal West Pico chemiluminescent substrate (Pierce) for up
to 5 min and then enclosed in transparent covers prior to exposure to x-ray film. Band
density was analyzed using the UN-SCAN-IT software package (Silk Scientific Inc.,
Orem, UH).
qPCR analysis of MKP-1, IL-6, TNF-α, and Cox-2. Total RNA was isolated,
including the recommended DNase treatment step, using the RNeasy Mini Kit (Qiagen,
Valencia, CA) and quantified using the NanoDrop Spectrophotometer ND-1000
(NanoDrop Technologies, Inc.). One µg of total RNA was used to synthesize the first
strand cDNA. First strand cDNA was synthesized with the RT2 PCR Array First Strand
Kit (SuperArray Bioscience Corporation, Frederick, MD). Using 10 ng starting RNA per
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sample, expression of pro-inflammatory cytokines (TNF-α and IL-6), Cox-2, and MKP-1
were determined by qPCR (iCycler iQ, Bio-Rad) using mouse-specific, certified primers
(SuperArray, Frederick, MD). Reaction mixtures were assembled in optical 96 well
plates using the RT-PCR SYBR Green Master Mix (SuperArray). Amplifications were
performed in an iCycler iQ (Bio-Rad) programmed for an initial step of 30 min at 50 °C
and 10 min at 95 °C, followed by 40 cycles at 95 °C for 15 s and 1 min at 60 °C. To
check the quality of the products, the melting curve program was run after the above
cycling program. The expression of GAPDH, which was verified of not being affected by
vehicle/Mn/LPS treatment, was used as a house-keeping gene for all samples. Data are
presented as relative induction (fold changes) of MKP-1, inflammatory cytokine, or Cox2 normalized to GAPDH. Data shown represent samples from four independent
experiments, and measurements were performed in duplicate.
Statistical Analysis. Data were analyzed using appropriate analysis of variance
(ANOVA). When statistical differences were detected (P < 0.05), treatment means were
separated by the Fisher’s LSD post hoc test. All data are presented as means + S.E.M.
Results
Immunoblot analysis of MKK and MKP-1. To determine the source of the
enhanced/prolonged p38 activation observed in the presence of Mn (Crittenden and
Filipov, 2008), we examined the induction of the MKK upstream of p38 (i.e. MKK-1/2, 3/6, -4), as well as its main negative regulator, the phosphatase MKP-1. Following
exposure to Mn (250 µM), with and without LPS (100 ng/ml) for up to 4 h, levels of non52

phosphorylated MKK-3/6 (all exposures) did not change in response to Mn and/or LPS
exposure. However, induction of MKK-3/6 phosphorylation was observed at 1 h post
exposure to Mn+LPS or LPS alone; this effect persisted through the 4 h time point
(Figures 3.1A and 3.1B, respectively). On the other hand, Mn by itself did not increase
the phosphorylation of MKK-3/6 at any time and the effect of Mn+LPS was not greater
than the effect of LPS (Figures 3.1A and 3.1B).
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Figure 3.1 Quantification and western blots shown representative of MKK-3/6
phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,
or 250 µM Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.
Densitometric data were adjusted relative to vehicle control and normalized
as a ratio of phosphorylated to total (non-phosphorylated) MKK-3/6 protein.
All data points represent means ± SEM from at least 3 independent
experiments. Data were analyzed with ANOVA and means were separated
using Fisher’s LSD multiple comparison post hoc test. Letters denote
statistically significant difference at p ≤ 0.05.
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Similar to MKK-3/6, Mn alone did not cause appreciable phosphorylation of
MKK-1/2 or MKK-4 at 1 or 4 h (Figures 3.2A, 3.2B, 3.3A, and 3.3B, respectively).
However, at 1 h, the combination of Mn+LPS significantly increased the phosphorylation
of both MKK-1/2 and MKK-4 to levels greater than the effect of LPS alone (Figures
3.2A and 3.3A). This effect was transient, as no statistical differences were observed in
the presence of Mn or LPS for MKK-1/2 or MKK-4 at 4 h post exposure (Figures 3.2B
and 3.3B).
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Figure 3.2 Quantification and western blots shown representative of MKK-1/2
phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,
or 250 µM Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.
Densitometric data for phosphorylated MKK-1/2 are represented as total
pixel density. All data points represent means ± SEM from at least 3
independent experiments. Data were analyzed with ANOVA and means
were separated using Fisher’s LSD multiple comparison post hoc test.
Letters denote statistically significant difference at p ≤ 0.05.
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Figure 3.3 Quantification and western blots shown representative of MKK-4
phosphorylation following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS,
or 250 µM Mn + 100 ng/ml LPS for 1 (A) and 4 (B) h.
Densitometric data for phosphorylated MKK-4 are represented as total pixel
density. All data points represent means ± SEM from at least 3 independent
experiments. Data were analyzed with ANOVA and means were separated
using Fisher’s LSD multiple comparison post hoc test. Letters denote
statistically significant difference at p ≤ 0.05.
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Based on published observations in primary microglia (Zhou et al., 2007), Dex
with and without LPS was used as a positive MKP-1 control. Similar to primary
microglia, Dex+LPS, but not Dex alone, was able to increase the MKP-1 protein levels at
both 1 and 4 h in N9 microglia (Figures 3.4A and 3.4B). Dexamethasone alone
decreased MKP-1 protein levels at 1 h, an effect that was not observed at 4 h (Figures
3.4A and 3.4B, respectively). In LPS- and Mn+LPS-treated cells, MKP-1 protein levels
were also increased at 1 h (Figure 3.4A). However, MKP-1 protein levels in cells
exposed to Mn were decreased relative to controls at the 1 h time point (Figure 3.4A). A
similar decrease in MKP-1 levels was observed in Mn+LPS exposed cells relative to LPS
alone (Figure 3.4A). Interestingly, the magnitude of the decrease was similar in both Mn
and Mn+LPS exposed cells, relative to their respective controls (i.e. vehicle and LPS).
At 4 h, a rebound effect was observed, as MKP-1 protein expression had significantly
increased by in the Mn- and Mn+LPS-exposed cells (Figure 3.4B).
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Figure 3.4 Quantification and western blots shown representative of MKP-1
following exposure to vehicle, 250 µM Mn, 100 ng/ml LPS, 250 µM Mn +
100 ng/ml LPS, Dex 1 µM, or Dex 1 µM + 100 ng/ml LPS for 1 h (A) and 4
h (B).
Densitometric data for MKP-1 are represented as total pixel density.
All data points represent means ± SEM from at least 3 independent
experiments. Data were analyzed with ANOVA and means were separated
using Fisher’s LSD multiple comparison post hoc test. Letters denote
statistically significant difference from control and bars with different
letters are statistically different from each other at p ≤ 0.05.
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qPCR analysis of MKP-1. Similar to the MKP-1 protein levels, decreased
expression of MKP-1 mRNA was observed for Mn-exposed cells at 1 h relative to the
vehicle control (Figure 5A). Although Mn+LPS increased the overall expression of
MKP-1 mRNA relative to the vehicle or Mn alone, the effect was less than that of LPS
alone (Figure 3.5A). Interestingly, the magnitude of the change in MKP-1 mRNA
expression in cells exposed to Mn-alone or in combination with LPS, relative to their
respective controls (vehicle and LPS), was similar (almost 2-fold decrease; Figure 3.5).
Exposure to Dex or LPS increased MKP-1 mRNA expression (2- and 5-fold,
respectively). As expected, the largest increase in MKP-1 mRNA expression was
observed in the presence of Dex+LPS, the positive control (7.5-fold; Figure 3.5A).
In contrast to the 1 h data, and in agreement with the western blot data, Mn
increased the expression of MKP-1 mRNA at 4 h (Figure 3.5B). Although the amounts
of MKP-1 mRNA in Dex, LPS, Mn+LPS, and Dex+LPS at 4 h were diminished in
comparison to 1 h exposures, MKP-1 mRNA in Mn+LPS exposed cells was significantly
increased in comparison to LPS alone at 4 h (Figure 3.5B).
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qPCR analysis of TNF-α, IL-6, and Cox-2. To examine the temporal
expression of the inflammatory cytokines TNF-α and IL-6, as well as Cox-2, following
exposure to Mn and/or LPS, we quantified TNF-α, IL-6, and Cox-2 mRNA at 1 and 4 h
post exposure. Mn exposure by itself did not affect TNF-α mRNA at either time point
(Figures 3.6A and 3.6B). Exposure to LPS, on the other hand, significantly increased
TNF-α mRNA about 100-fold at 1 h in comparison to control, and this effect diminished
by 4 h (Figures 3.6A and 3.6B). Similar to the effect observed with LPS alone, Mn+LPS
significantly increased TNF-α mRNA at 1 h, with the effect of Mn+LPS on TNF-α
expression being moderately greater than the effect of LPS alone (Figure 3.6A). While
the LPS effect diminished substantially by 4 h, the Mn+LPS effect persisted, thus
allowing for much greater TNF-α mRNA levels at 4 h in the Mn+LPS group compared
to the LPS alone treatment (Figure 3.6B).
In accord with the TNF-α mRNA data, LPS significantly increased expression of
IL-6 mRNA at 1 h and 4 h (Figures 3.6C and 3.6D). Similar to TNF-α, no effect on IL-6
mRNA expression was observed following exposure to Mn alone (Figures 3.6C and
3.6D). Interestingly, although Mn+LPS increased IL-6 expression at 1 h, in contrast to
the effect of Mn+LPS on TNF-α, this effect was not greater than the effect of LPS alone
(Figure 3.6C). However, similar to TNF-α, the expression of IL-6 mRNA in cells
exposed to Mn+LPS increased over time from 1 to 4 h, almost 10-fold (Figure 3.6D).
This effect was specific for Mn+LPS, as IL-6 mRNA in LPS-alone exposed cells,
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although significantly greater than vehicle, did not increase between the 1 and 4 h time
points (Figures 3.6C and 3.6D).
As recent data have suggested that non-cytokine inflammatory molecules, such as
prostaglandin E-2 (PGE2), may be important in Mn-induced inflammation (Liao et al.,
2007), we also quantified Cox-2 mRNA in the presence of Mn and/or LPS at 1 and 4 h.
Although exposure to LPS and Mn+LPS increased the expression of COX-2 mRNA by
20-fold at 1 h, the effect of Mn in combination with LPS was not greater than LPS alone
(Figure 3.6E). However, similar to TNF-α and IL-6, by the 4 h time point, Mn+LPS
exposure had increased Cox-2 mRNA even further to 30-fold. In contrast, the LPSinduced increase in Cox-2 mRNA, although still present, was only 11-fold (Figure 3.6F).
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Discussion
Previous research has demonstrated that Mn exposure, in combination with an
inflammogen, can increase the production of iNOS/NO (Chang and Liu, 1999; Barhoumi
et al., 2004; Filipov et al., 2005; Chen et al., 2006), PGE2 (Liao et al., 2007), as well of
the inflammatory cytokines TNF- α (Filipov et al., 2005; Chen et al., 2006) and IL-6
(Filipov et al., 2005) by glial cells. Although Mn alone increases cytokine production in
microglia, the increase is small and only at high concentrations of Mn, suggesting that
prior/ongoing microglial activation is necessary for Mn-potentiation of at least TNF-α
and IL-6 to be observed (Filipov et al., 2005). The cause of the Mn-induced potentiation
is not understood. However, several potential mechanisms have been explored involving
the TLR4 signaling pathway.
Activation of macrophages and microglia by LPS is thought to occur (primarily)
by binding of LPS to TLR4, leading to activation of intracellular kinases (i.e. MAPK)
and transcription factors such as NF-κB (Barton and Medzhitov, 2003; Takeda and Akira,
2004). Moreover, activation of the MAPK and NF-κB by LPS results in the production of
inflammatory mediators such as NO and TNF-α (Lee et al., 1993; Lee et al., 1994; Bhat
et al., 1998). In earlier studies, the effects of Mn on the production of inflammatory
molecules by activated glia was shown to involve the activation of the transcription factor
NF-κB (Barhoumi et al., 2004; Filipov et al., 2005; Chen et al., 2006). Additionally, this
effect is associated with the increased activation of MAPK (Bae et al., 2006), particularly
p38 (Zhang et al., 2007; Crittenden and Filipov, 2008), which appears to be long lasting
(Crittenden and Filipov, 2008).
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In our current study, we examined the key signaling molecules that may be
responsible for the prolonged activation of p38. The upstream MAPKs, MKK-3 and -6,
can activate p38, leading to the production of inflammatory mediators (Igarashi et al.,
2000; Fujishiro et al., 2001). However, based on our results, the enhanced and prolonged
p38 activation observed in Mn-exposed, LPS-stimulated microglia (Crittenden and
Filipov, 2008) is not the result of enhanced MKK-3/6 activation. Indeed, at all time
points examined in our study, the combination of Mn+LPS was no more effective than
LPS alone in inducing MKK-3/6 phosphorylation.
Although MKK-3 and -6 are considered to be the kinases primarily responsible
for phosphorylating p38, data also suggest that MKK-1, -4, and –7 may be involved in
p38 phosphorylation (Jiang et al., 1997; Chan-Hui and Weaver, 1998; Zarubin and Han,
2005). In the present study, Mn in combination with LPS increased phosphorylation of
both MKK-1/2 and MKK-4 above the increase caused by LPS alone. This may
contribute to the enhanced and prolonged p38 activation we have reported recently
(Crittenden and Filipov, 2008). Of note, both kinases have been shown to activate other
MAPKs, including ERK and JNK for MKK-1/2 and MKK-4, respectively (Koistinaho
and Koistinaho, 2002). Considering that ERK did not appear to play as important of a
role in the enhanced TNF-α and IL-6 production by Mn as did p38 (Crittenden and
Filipov, 2008), increased MKK-1/2 activity by Mn+LPS may only play a partial role in
the persistent activation of p38 associated with the enhanced cytokine production we
observed in Mn+LPS exposed microglia (Crittenden and Filipov, 2008).
Another possible explanation for increased and/or prolonged p38 phosphorylation
caused by Mn exposure which we investigated in this study is decreased activity of the
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phosphatase MKP-1 which is responsible for deactivating p38. The DUSPs, particularly
MKP-1, are important regulators of the innate immune responses. Overexpression of
MKP-1 in macrophages has been shown to inhibit phosphorylation of MAPK and
production of inflammatory cytokines (Chen et al., 2002; Shepherd et al., 2004; Zhao et
al., 2005). Conversely, reduced expression of MKP-1 results in increased production of
the inflammatory cytokines TNF-α and IL-6 (Chi et al., 2006; Hammer et al., 2006).
This observation is in line with our current findings demonstrating that exposure to Mn
for 1 h leads to reduced expression of MKP-1 protein. We also observed that MKP-1
was inhibited by Mn, but Mn alone does not increase IL-6 and TNF-α (Filipov et al.,
2005). These data corroborate our previous findings where Mn alone increased p38
activity, but did not increase IL-6 and TNF-α cytokine production and further highlight
the fact that persistent increase of p38 activity by Mn is necessary, but not sufficient, for
the increased cytokine production previously observed (Crittenden and Filipov, 2008).
As TLR signaling not only promotes the expression of MKP-1 mRNA, but also
prolongs the half-life of the transcript, it was necessary to examine both protein and
mRNA expression in the presence of Mn (Hammer et al., 2005). Similar to results we
obtained for MKP-1 protein, we observed a decrease in MKP-1 mRNA expression
following exposure to Mn for 1 h. Likewise, compared to the LPS alone treatment, the
decreased MKP-1 mRNA level following exposure to Mn+LPS was of the same
magnitude as the decrease caused by the Mn-only treatment (as compared to vehicle
control). Thus, the reduction in MKP-1 mRNA and protein expression could result in
prolonged p38 activation and enhanced pro-inflammatory cytokine production, as we
have reported (Crittenden and Filipov, 2008).
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We believe the reduction in MKP-1 mRNA and protein at 1 h leads to prolonged
p38 activity, which in turn stimulates feedback inhibition of the p38 pathway by
promoting MKP-1 expression. Indeed, activation of TLR4 by LPS has been shown to
increase the expression of MKP-1 via MyD88, PKC, as well as other MAPK, including
JNK and ERK, leading to feedback inhibition of p38 (Lang et al., 2006). It is possible
that the prolonged p38 activity observed in the presence of Mn, stimulates feedback
inhibition that is not effective through the 1 h time point because of the reduced
expression of MKP-1 caused by Mn. However, the ‘rebound’ of MKP-1 expression
observed at 4 h in Mn-exposed cells indicates the cell is compensating, albeit too late, to
prevent the prolonged activation of p38 and the enhanced production of inflammatory
cytokines, such as TNF-α and IL-6 (Filipov et al., 2005; Crittenden and Filipov, 2008)
and, perhaps, other inflammatory mediators, such as PGE2 (Liao et al., 2007).
Although we have previously reported increased production of inflammatory
cytokines by microglia exposed to Mn+LPS for 24 h in vitro at the protein level (Filipov
et al., 2005; Crittenden and Filipov, 2008), we did not examine cytokine mRNA
expression. Previous studies have suggested that Mn+LPS exposure results in increased
TNF-α (Chen et al., 2006) and Cox-2 (Liao et al., 2007) mRNA expression by mixed
glial cells at 6 h post exposure. In accord with these data, compared to the effects of LPS
alone, we observed that TNF-α, IL-6, and Cox-2 mRNA levels in cells exposed to
Mn+LPS were markedly greater at 4 h post exposure. In contrast, at 1 h post exposure,
except for a moderate potentiating effect on TNF-α, presence of Mn in the culture
medium did not enhance inflammatory mediator mRNA above the effects of LPS alone.
On the contrary, LPS increased the expression of IL-6 mRNA more than Mn+LPS at the
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1 h time point. However, by the 4 h time point, increased IL-6 mRNA expression
persisted in Mn+LPS exposed cells, while the effect of LPS diminished. Intuitively, it
would be reasonable to assume a correlation between an increased inflammatory
mediator message expression and prolonged p38 activity. Indeed, as we reported
(Crittenden and Filipov, 2008), Mn+LPS effects on p38 were not different from these of
LPS alone at 1 h post exposure. However, by 4 h, LPS-caused activation of p38 was no
longer present, while the presence of Mn in the exposure solution maintained p38 in its
activated state.
Taken together, as depicted on Figure 3.7, early dysregulation of feedback control
of MAPK signaling by Mn exposure, specifically MKK-1, MKK-4, p38, and MKP-1, is
associated with enhanced inflammatory mediator mRNA expression by microglia and
may lead to prolonged inflammation in brain tissue, resulting in excessive neuronal
damage and death.
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Figure 3.7 The effect of Mn on selected components of the MAPK cascade. Arrows
indicate relative increase or decrease, with larger arrows indicating a greater
effect than smaller arrows.
Abbreviations: MKK-1/2 (Mitogen Activated Protein Kinase Kinase-1/2),
MKK-3/6 (Mitogen Activated Protein Kinase Kinase-3/6), MKK-4 (Mitogen
Activated Protein Kinase Kinase-4), ERK (Extracellular Signal-Regulated
Kinase), p38 (p38 mitogen activated protein kinase), JNK (c-Jun N-terminal
Kinase), MKP-1 (mitogen activated protein kinase phosphatase-1).
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CHAPTER IV
MANGANESE POTENTIATION OF MICROGLIAL INFLAMMATORY
CYTOKINE PRODUCTION IS NOT RESTRICTED
TO ACTIVATION VIA TLR4
Abstract
Previous studies have investigated the potentiation of lipopolysaccharide (LPS, a
Toll-like receptor [TLR] agonist)-induced inflammatory mediators, such as NO and
cytokines (IL-6 and TNF-α) by manganese (Mn) in primary microglia, microglial cell
lines, and mixed glial cultures. Although the molecular mechanism(s) of the observed
Mn-potentiation is not well understood, it is clear that transcription factors like NF-kB
and prolonged activation of mitogen-activated protein kinases (MAPK), such as p38, are
required. However, Mn-potentiation in microglial cells activated by TLR ligands other
than LPS has not been explored. In the current study, to determine if Mn-potentiation
was dependent on a specific TLR or TLR-associated signaling pathway, we examined
Mn-potentiation of IL-6 and TNF-α in N9 microglia stimulated with ligands specific for
TLR4 (LPS), TLR 2 (Deoxyribonucleic acid; CpG), TLR9 (Peptidoglycan; GPG), or
TLR3 (Polyinosinic: polycytidylic acid; pI:C). In addition, we also examined the
involvement of p38, ERK, and JNK in the potentiating effects of Mn. Manganese (24 h
exposure) dose-respondantly potentiated secretion of pro-inflammatory cytokine proteins
in all TLR-activated microglia. Additionally, Mn exposure potentiated TNF-α mRNA in
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microglia activated with LPS, pI:C, CpG, or GPG at 4 h. The production of IL-6 mRNA
at 4 h on the other hand, was differentially effected, with the greatest potentiating effect
of Mn observed for LPS and pI:C. Although enhanced p38 activation by Mn was
observed at 4 h following activation by all TLR-ligands, pharmacological inhibition of
p38, JNK, or ERK decreased IL-6 and TNF-α production in all Mn-exposed, TLRstimulated N9 microglia. These results indicate that Mn-potentiation is not limited to
LPS-activated microglia, and potentiation can occur for an array of TLR-ligands working
through at least four distinctive TLRs. Moreover, as Mn-potentiation occurred in both
TLR2- and TLR3-stimulated cells, the observed potentiation may not be dependent on
the TLR2/4/9-associated adaptor molecule, MyD88.
Introduction
Manganese (Mn), a ubiquitously distributed environmental contaminant (Aschner,
2000), in cases of excessive exposure can induce neurotoxicity that is characterized by a
neurodegeneration that results in psychiatric symptoms and extrapyramidal neurologic
deficits (Dobson et al., 2004). Although the mechanism of this neurodegeneration is
largely attributed to the ability of Mn to stimulate the generation of cytotoxic free radicals
(Aschner and Aschner, 1991; Gavin et al., 1999; HaMai and Bondy, 2004), it has been
shown that neurodegeneration may also be due to the effects of Mn on the non-neuronal
cells of the brain, astroglia and microglia. This is relevant in the context of Mn-induced
inflammation, as it has been shown that glia, especially activated glia, produce
significantly more NO, TNF-α, and IL-6 when exposed to Mn (Chang and Liu, 1999;
Filipov et al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008). Importantly,
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increased expression of inflammatory mediators has been linked with neuronal cell injury
and death (Liu et al., 2002; Hald and Lotharius, 2005) and with elevated inflammatory
cytokine expression in animal models of Parkinson’s Disease (PD), as well as in the
brains of PD patients (Nagatsu et al., 2000; Sriram et al., 2002). This is further supported
by the observations that blockage or deletion of inflammatory mediators can attenuate
basal ganglia neurotoxicity induced by the PD model toxicant, 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP; Sriram et al., 2002; Heales et al., 1999; Ferger et al.,
2004).
Inflammation, while necessary for defense and tissue growth, may cause
irreversible damage when prolonged or chronic in nature. In the brain, inflammatory
mediators are produced by microglia and/or astroglia. Once activated by inflammogens
such as lipopolysaccharide (LPS), a known environmental contaminant (Niehaus and
Lange, 2003), these cells have been shown to produce inflammatory mediators like nitric
oxide (NO), reactive oxygen species (ROS), and the cytokines interleukin-6 and tumor
necrosis factor (IL-6 and TNF-α, respectively; Chao et al., 1992; Jeohn et al., 2002a;
Jeohn et al., 2002b; Liu et al., 2002). Moreover, Mn has been shown to enhance the
production of inflammatory mediators in LPS-activated glia (Filipov et al., 2005; Liu et
al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008). Although the mechanism of
Mn-potentiation of inflammatory mediator production in LPS-activated glia is still being
explored, it has been demonstrated that several key intracellular signaling molecules are
involved, all of which are activated by Toll-like Receptors (TLR; Filipov et al., 2005; Liu
et al., 2005; Chen et al., 2006; Bae et al., 2006; Crittenden and Filipov, 2008).
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Activation of cells of the innate immune system (i.e. macrophages and microglia)
by LPS and other inflammogens (i.e. bacterial peptidoglycan, bacterial DNA, viral RNA),
is thought to be primarily dependent on the activation of TLR (Beutler, 2004; Takeda and
Akira, 2004). Perhaps the most well studied TLR activation pathway is the signaling
initiated by binding of LPS to TLR4 (Beutler, 2004; Takeda and Akira, 2004). Binding
of LPS to the TLR4 cell surface receptor initiates a signaling cascade via the adaptor
molecule MyD88, which culminates in the activation of downstream kinases and
transcription factors (Beutler, 2004; Takeda and Akira, 2004). In comparison, two other
TLR that utilize the MyD88-dependent pathway for initiating intracellular activation are
TLR2 and TLR9 when these receptors are ‘activated’ by their ligands, Gram positive
bacterial cell wall peptidoglycan (GPG) and bacterial DNA (CpG), respectively (Beutler,
2004; Takeda and Akira, 2004). This is in contrast to MyD88-independent TLRsignaling that requires an alternative adaptor molecule, Toll-receptor-associated activator
of interferon (TRIF), which is utilized primarily by TLR3 upon activation by its ligand,
dsRNA (pI:C; Beutler, 2004; Takeda and Akira, 2004). Although primarily signaling
through MyD88, evidence also suggests that, in contrast to TLR2 and TLR9, some of the
TLR4 signaling may be MyD88-independent (Beutler, 2004; Takeda and Akira, 2004).
Once activated, these TLR initiate a signaling cascade that culminates with the activation
of NF-kB and the mitogen activated protein kinase (MAPK) cascade (Koistinaho and
Koistinaho, 2002; Beutler, 2004; Takeda and Akira, 2004).
Activation of the MAPK cascade begins with the phosphorylation of the map
kinase kinase kinase TAK1, which in turn phosphorylates ‘downstream’ map kinase
kinases (MKK), MKK-1, -2, -3, -4, and -6, which subsequently phosphorylate their
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‘downstream’ targets, the MAPK (Koistinaho and Koistinaho, 2002; Beutler, 2004;
Takeda and Akira, 2004).
The MAPK are composed of three major kinases, including p38 MAPK (p38),
extracellular signal-regulated kinase (ERK), and the stress-activated or c-Jun N-terminal
kinase (JNK; Koistinaho and Koistinaho, 2002). Indeed, this is the case for activated
primary microglia and microglial cell lines, as LPS stimulation increases the
phosphorylation of p38, ERK, and JNK, as well as the expression of inflammatory
mediators (Lee et al., 1993; Lee et al., 1994; Bhat et al., 1998; Chen et al., 2006).
Furthermore, neuronal survivability in neuronal-glia co-culture is decreased in LPSactivated microglia, an effect that can be inhibited by pretreatment with inhibitors of p38
(Bhat et al., 1998; Jeohn et al., 2002a; Jeohn et al., 2002b).
In the context of Mn-potentiation of inflammatory cytokines by LPS-stimulated
microglia, we have demonstrated that potentiation is dependent on NF-kB and p38, as
inhibitors of NF-kB and p38 were able to prevent enhanced IL-6 and TNF-α production
in Mn+LPS cells (Filipov et al., 2005; Crittenden and Filipov, 2008). Additionally, we
have shown that p38 phosphorylation (activation) and p38 kinase activity is prolonged in
the presence of Mn+LPS, relative to LPS alone, suggesting that the increased
inflammatory cytokines in Mn+LPS-exposed cells is partly due to dysregulation of the
p38 signaling pathway (Crittenden and Filipov, 2008). Moreover, we have demonstrated
that this effect is independent of the timing of exposure to Mn, as exposure to Mn 3 h
before or after LPS potentiated IL-6 and TNF-α production (Crittenden and Filipov,
2008). Furthermore, we have demonstrated that enhanced p38 activation is, in part, due

75

to enhanced activation of ‘upstream’ MKK-1/2 and -4, as well as decreased activity of
the phosphatase, mitogen kinase phosphatase-1 (MKP-1; Chapter III).
However, the potentiating effect of Mn in microglia activated by TLR ligands
other than LPS has not been studied and, perhaps, examining the distinctive TLR
signaling pathways may provide information regarding the mechanism of Mn-potentiated
inflammation previously observed for LPS-stimulated cells. To address these questions,
in this study, our objectives were to (i) determine if Mn can potentiate inflammatory
cytokine production (protein and mRNA) in N9 microglia stimulated with TLR-ligands
other than LPS, (ii) if Mn-potentiation is observed for TLR-ligands other than LPS,
determine whether p38 activation is associated with the Mn-potentiation, and (iii) using
pharmacological inhibition, determine the role of the three major MAPK (i.e. p38, ERK,
and JNK) for each Mn-TLR ligand combination.
Materials and Methods
Chemicals. Manganese (MnCl2; 1 M stock) was purchased from Sigma-Aldrich
(Sigma; St. Louis, MO) with purity >99.9 %, and was used for all experiments. TLR
ligands utilized in this study were lipopolysaccharide (LPS, Escherichia coli 011:B4;
Sigma), Polyinosinic-polycytidylic acid potassium salt (pI:C; Sigma), Peptidoglycan
(GPG; Sigma), or CPG deoxyribonucleic acid (CpG; Cell Signaling, Inc.).
Cell Culture. For all experiments, the retroviral-immortalized brain microglial
cell line, N9, was used. The N9 cell line was the kind gift of Dr. P. Ricciardi-Castagnoli
(University of Milan, Italy), and is derived from day13 embryonic mouse brain cultures.
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The N9 cell line is similar to another cell line, N13, as well as primary microglia, in that
both produce inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, as well as NO
when activated by LPS (Righi et al., 1989; Heyen et al., 2000).
All cultures were maintained at 37° C (5% CO2 with 95% air) in RPMI-1640
supplemented with 10% FBS (low endotoxin, ≤ 25 EU/ml; Hyclone, Logan, UT),
0.075% sodium bicarbonate, 1 mM sodium pyruvate, 1 mM non-essential amino acids, 2
mM L-glutamax, 50 µM 2-mercaptoethanol, 25 µg/ml gentamycin, 100 U/ml penicillin
G, and 100 mg/ml streptomycin (all from Invitrogen, Carlsbad, CA). For
pharmacological inhibition and cytokine studies, cells were seeded at 0.25 x 106
cells/well (0.5 ml volume) in 48-well plates (Costar; Fisher Scientific, Pittsburgh, PA).
For western blot and mRNA analysis, cells were seeded at 2.5 x 106 cells/well (5 ml
volume) in 6-well plates (Costar). Cells were incubated for up to 24 h in the presence of
Mn (100 or 250 µM), Gram negative bacterial Lipopolysaccharide (LPS, Escherichia coli
011:B4; 100 ng/ml), synthetic viral RNA Polyinosinic-polycytidylic acid potassium salt
(pI:C; 50 µg/ml), Gram positive bacterial peptidoglycan (GPG, Staphylococcus aureus; 5
µg/ml), or synthetic bacterial deoxyribonucleic acid (CpG; 200 nM).
The Mn and LPS exposures used in this study were consistent with reported
environmental exposures and previous studies as described in previously published work
(Crittenden and Filipov, 2008).
Cytokine Analysis. To quantify the amounts of IL-6 and TNF-α, we used
DuoSet ELISA kits from R&D Systems, Inc, Minneapolis, MN) and manufacturer’s
instructions were followed. Briefly, 96-well microplates (Costar) were coated for
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overnight at 4 C with their respective capture antibody in PBS. The plates were then
washed with PBS-Tween buffer (3x) and blocked (1% BSA in PBS) for 1 h at RT. Then,
the samples or standards were applied to individual wells and incubated for 2 h at RT.
Next, the plates were washed 3x, incubated with detection antibody for 2 h, followed by
another 3x wash. Strepavidin-HRP conjugate was added to each well for 20 min at RT,
plates were washed 3x, and TMB-based substrate was added to each well and allowed to
develop up to 30 min. To stop the reaction, 50 µl of 2N H2SO4 was added to each well
and the absorbance was read using a Spectramax Plate Reader (Molecular Devices,
Sunnyvale, CA) at 450 nm. For each cytokine, samples were assayed in duplicate and
standard curves run on each plate were utilized to estimate the mean for each sample.
Pharmacological manipulation. For pharmacological inhibition of p38, JNK,
and ERK, the inhibitors SB203580, SP600125, and UO126, respectively, (Calbiochem,
San Diego, CA), were added 1 h prior to exposure to Mn and/or TLR ligand. The
inhibitors were dissolved in DMSO (25.4 mM) and stored and –80°C until diluted to a
working concentration of 2.5 mM prior to use. For actual experiments, inhibitors were
diluted in the culture media to the final concentration of 25 µM. Thus, exposure to
DMSO was at 0.1% for vehicle and MAPK-inhibitor exposed cells and it had no effect
on cellular function.
qPCR analysis of IL-6 and TNF-α. Gene expression for IL-6 and TNF-a was
determined using qPCR. Briefly, total RNA was isolated using the RNeasy Mini Kit
(Qiagen, Valencia, CA) and all samples were treated with DNase to remove any
contaminating genomic DNA. Total RNA was quantified using the NanoDrop
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Spectrophotometer ND-1000 (NanoDrop Technologies, Inc.) and 1 µg of total RNA was
used to synthesize the first strand cDNA with the RT2 PCR Array First Strand Kit
(SuperArray Bioscience Corporation, Frederick, MD). Starting with 10 ng of RNA per
sample, expression of the cytokines IL-6 and TNF-α was determined by qPCR (iCycler
iQ, Bio-Rad) using mouse specific primers (SuperArray). Each reaction mixture was
combined within an individual well of a 96-well plate using the RT-PCR SYBR Green
Master Mix (SuperArray) and amplifications were performed using an iCycler iQ (BioRad). Reactions were amplified using an initial step of 30 min at 50 °C and 10 min at 95
°C, followed by 40 cycles at 95 °C for 15 s and 1 min at 60 °C. To determine the quality
of the products, a melting curve program was ran after the cycling program. For
determination of baseline message expression, the expression of the house-keeping gene
GAPDH was verified as not being affected by vehicle/Mn/LPS treatment. Data are
presented as relative induction (fold-change) of pro-inflammatory cytokine. Data shown
are representative of up to four independent experiments and measurements were
performed in duplicate.
Immunoblot Analysis of p38 MAPK Following incubation for 1 or 4 h, cells
were removed by scraping, centrifuged at 300 xg for 10 min a 4 °C, resuspended in 100
µl of RIPA (modified radioimmunoprecipitation) lysis buffer (1x PBS, 1% Igepal, 0.5%
sodium deoxycholate, 0.1% SDS) containing PMSF (Sigma), protease and phosphatase
inhibitors (Protease Inhibitor Cocktail, Sigma, and HALT Phosphatase Inhibitor Cocktail,
Pierce, [Rockford, IL], respectively), and held on ice for 30 min with occasional pipetting
to disrupt cell membranes. The cell lysate protein concentration was determined using
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the Bradford method with reagents obtained from Bio-Rad and with bovine serum
albumin (BSA) as a standard. Sample aliquots were denatured in reducing
sample buffer by heating for 5 min at 95 °C. Samples were electrophoretically
separated by loading 20 µg of total protein per well in a 10% SDS-PAGE gel, transferred
to a PVDF membrane, and the membranes were blocked in 5% milk for at least 1 h at
RT.
All membranes were incubated overnight at 4 °C with antibody specific for
phosphorylated p38 MAPK (1:500) or non-phosphorylated p38 MAPK (1:3000) (Cell
Signaling Technology, Beverly, MA). Following incubation, each membrane was rinsed
(3x) and washed (4x) for 15 min per wash. Then, each membrane was probed with goat
anti-rabbit secondary antibody conjugated with horseradish peroxidase (1:10,000, BioRad) for 1.5 h at RT. Next, the blots were exposed to SuperSignal West Pico
chemiluminescent substrate (Pierce) for up to 5 min and then enclosed in transparent
covers prior to exposure to x-ray film. Band density was analyzed using the UNSCANIT software package (Silk Scientific Inc., Orem, UH).
Statistical Analysis. Data were analyzed using appropriate analysis of variance
(ANOVA). When statistical differences were detected (P < 0.05), treatment means were
separated using Fisher’s LSD post hoc test. All data are presented as means ± S.E.M.
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Results
IL-6 and TNF-α protein expression. To determine whether Mn can potentiate
inflammatory cytokine production by microglia activated by different TLR ligands,
similar to the effects of Mn on LPS-activated microglia as we have previously reported
(Filipov et al., 2005; Crittenden and Filipov, 2008), we exposed N9 microglia to LPS,
pI:C, CpG, or GPG, alone or in combination with Mn (100 or 250 µM), for 24 h. As
previously reported, except for a small increase TNF-α by Mn (250 µM; Figures 4.1A),
neither vehicle nor Mn alone induced significant cytokine (Figures 4.1A and 4.1B;
Filipov et al., 2005; Crittenden and Filipov, 2008). Inflammatory cytokine (IL-6 and
TNF-α) production was significantly increased in microglia exposed to LPS, pI:C , CpG,
and GPG (Figures 4.1A and 4.1B). The increase in media TNF-α levels was highest for
cells exposed to LPS and pI:C (Figure 4.1A). While not as effective as LPS or pI:C at the
concentrations used, CpG and GPG also significantly increased microglial TNF-α
production (Figure 4.1A). Similar results were observed for IL-6, as all four TLR ligands
increased IL-6 protein in the supernatant, with the highest levels of cytokine observed in
pI:C and LPS exposed cells (Figure 4.1B).
Co-exposure to Mn (100 or 250 µM) and LPS, pI:C, CpG, or GPG potentiated
TNF-α and IL-6 in a dose-responsive manner (Figures 4.1A and 4.1B). The most
profound effect on TNF-α potentiation was observed in cells co-exposed to 250 µM Mn
and CpG or GPG with a 3-fold increase in TNF-α compared to TLR ligand alone,
although significant potentiation of TNF-α by Mn was observed for LPS and pI:C as well
(Figure 4.1A). Manganese potentiated IL-6 production for all TLR ligands (LPS, pI:C,
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CpG, GPG), with the greatest effects observed for 250 µM Mn in combination with pI:C
or CpG, with overall increases of 3- and 4-fold (respectively) in comparison to the TLR
ligands alone (Figure 4.1B).
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Figure 4-1

Effect of exposure to manganese (Mn) and/or lipopolysaccharide (LPS),
polyinosinic:polycytidylic acid (pI:C), peptidoglycan (GPG), microbial
DNA (CpG) on microglial inflammatory cytokine production.
TNF-α (1A) and IL-6 (1B) production was analyzed in supernatants
collected 24 h after exposure to N9 microglial cells to Mn (100 or 250 µM),
and/or LPS (100 ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG (5 µg/ml).
Media levels of TNF-α and IL-6 were analyzed by respective DuoSet
ELISA as described in Materials and Methods. Data shown in each bar
represent the mean ± SEM, of 4 independent replicates. a,b,c Presence of
letters on top of bars indicate treatment differences relative to vehicle/Mn
250 or within a particular TLR ligand-Mn combination for TNF-α (1A) and
IL-6 (1B) levels with bars with different letters being different from each
other and from bars without a letter (p ≤ 0.05). # Indicates significant
effect of Mn (p ≤ 0.05)
83

IL-6 and TNF-α mRNA expression. To determine whether Mn-potentiation of
TNF-α and IL-6 occurred at the level of mRNA transcription, inflammatory cytokine
mRNA expression was quantified using q-PCR. The TLR ligands alone significantly
increased TNF-α and IL-6 mRNA expression, respectively (Figure 4.2A and 4.2B,
respectively).
Manganese potentiated TNF-α mRNA expression for all TLRs at 4 h (Figure
4.2A). The highest TNF-α mRNA potentiation by Mn was observed for LPS and pI:C
(2.5 and 4-fold increases, respectively), with a smaller, but significant, increase observed
for CpG and GPG as well (Figure 4.2A). Somewhat in contrast to TNF-α mRNA
induction, IL-6 mRNA expression was significantly potentiated by Mn in only the LPSand pI:C-exposed cells, while the Mn-potentiation observed in CpG- or GPG-stimulated
cells was only marginal and did not reach significance (Figure 4.2B).
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Fold change (up/down from vehicle control) in TNF-α (A) and IL-6 (B)
mRNA expression following exposure to 250 µM Mn and/or LPS (100
ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG (5 µg/ml).
All data points represent means ± SEM from 3 or more independent
experiments. Data were analyzed with ANOVA and means were separated
using Fisher’s LSD multiple comparison post hoc test. a,b Letters denote
statistically significant difference at p ≤ 0.05 and represent differences from
vehicle and Mn within particular TLR ligand-Mn combination.
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Immunoblot analysis of p38 and phospho-p38 protein. To examine p38
activation, we measured p38 phosphorylation (normalized to non-phosphorylated p38)
following exposure to TLR-ligands alone, or in combination with 250 µM Mn at 4 h.
Similar to previously published data (Crittenden and Filipov, 2008), LPS-induced p38
phosphorylation had subsided by 4 h and was not different from control, while 250 µM
Mn- or 250 µM Mn+LPS-induced p38 phosphorylation was still significantly increased
in comparison to vehicle control (Figure 4.3A ). Similar to LPS alone at 4 h, pI:C, CpG,
or GPG-induced p38 phosphorylation was not different from control (Figure 4.3A).
However, significantly increased p38 phosphorylation was observed for 250 µM Mn in
combination with pI:C, CpG, or GPG, with the largest increase being a 5-fold increase in
p38 phosphorylation for CpG (Figure 4.3A ). The levels of non-phosphorylated p38 (all
exposures) did not significantly change in response to Mn and/or TLR ligands (Figure
4.3A).
In comparison to previous work examining the effect of 1 h exposure to Mn and
LPS on p38 activation (Crittenden and Filipov, 2008), we quantified p38 phosphorylation
in N9 microglia exposed to Mn and another TLR ligand, pI:C, for 1 h. Co-exposure to
Mn and pI:C significantly increased p38 phosphorylation relative to pI:C alone, while the
level of p38 phosphorylation in cells exposed to Mn or pI:C was greater than control but
similar between the two (Figure 4.3B). Furthermore, in agreement with previously
published data for Mn and LPS (Crittenden and Filipov, 2008), the p38 phosphorylation
in microglia exposed only to pI:C diminished by 4 h (Figure 4.3A).

86

100

4h

75

b

50

a

a

b

a

25

G
PG

PG
G

n+
M

C
pG

n+

C
pG
M

n+

pI

:C

pI
:C
M

LP
S
M
n+
LP
S

M
n

0
Ve
h

Phospho-p38 MAPK
(Phospho-p38/Total p38)*100

A

pp38
___ ___ _________ __________
Veh Mn
LPS
Mn+LPS

p38

___ ___ __________ __________
Veh Mn
CpG
Mn+CpG

pp38
___ ___ __________ __________
Veh Mn
pI:C
Mn+pI:C

Figure 4-3

p38

___ ___ __________ __________
Veh Mn
GPG
Mn+GPG

Analysis of phosphorylated p38 kinase in N9 microglia exposed to (A)
250 µM Mn and/or LPS (100 ng/ml), pI:C (50 µg/ml), CpG (200 nM), GPG
(5 µg/ml) for 4 h or (B) 250 µM Mn and/or pI:C (50 µg/ml) for 1 h.
Western blots and densitometric analysis were performed as described in the
Materials and Methods. Data shown represent the means ± SEM of the
adjusted pixel density for phosphorylated p38 normalized to the
non-phosphorylated p38. For abbreviations please refer to the legend on
Fig.4-1. Each bar represents a minimum of 3 independent replicates.
a,b
Letters denote statistically significant difference at p ≤ 0.05 and represent
differences from vehicle, Mn, and/or TLR control.
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Effect of MAPK inhibitors on cytokine expression. To determine whether p38,
JNK, or ERK MAPK are required for Mn-potentiation of TNF-α or IL-6 in TLRactivated microglia, N9 cells were pretreated with inhibitors specific for either p38, JNK,
or ERK. As previously observed, p38 inhibition prevented both LPS-induced TNF-α
protein expression, as well as Mn-potentiation of LPS-induced TNF-α production (Figure
4.4A). Similarly, inhibition of JNK and ERK also prevented LPS-induced TNF-α
production, as well as Mn+LPS-induced TNF-α production (Figure 4.4A).
As observed with LPS-stimulated microglia, production of TNF-α in microglia
stimulated with CpG- or GPG-alone, or in the presence of Mn, was significantly inhibited
by all three inhibitors, with the greatest effect observed for JNK- and ERK-inhibitors
with near complete inhibition (Figures 4.4C and 4.4D). Unlike the previous TLR ligands
(LPS, CpG, and GPG), inhibition of TNF-α production in pI:C- or Mn+pI:C-activated
cells was greatest following inhibition of JNK or ERK, although all three inhibitors were
effective (Figure 4C).
As we have also previously observed for IL-6, prior exposure to SB203580
significantly inhibited IL-6 production in LPS- and Mn+LPS-exposed cells (Figure
4.5A). However, SP600125 and UO126 were the most effective at inhibiting IL-6
production in LPS-stimulated cells (Figure 4.5A). Similar to the inhibition observed with
LPS-stimulated cells, all MAPK inhibitors were effective at preventing IL-6 production
in CpG- or GPG-stimulated N9 microglia, with the greatest effect observed for SP600125
and UO126 (Figures 4.5C and 4.5D). In comparison to TNF-α, prior exposure to
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SB203580, SP60025, or UO126 prevented pI:C and Mn+pI:C-induced IL-6 production,
with the greatest effect observed for the p38 and JNK inhibitors (Figure 4.5B).

90

TNF-α (pg/ml)

3000
A
2500
2000
1500
1000
1000

3000
2750
2500
2250
2000
2000

c
b
e

800

1200

g
f

400

a

200

a

400

e

e

800

f

0

d

a

f

a

V

eh
ic
l
M e
n2
50

M
n2 L P
50 S
+L
PS
M
n2 L P
50 S/S
+L B
PS
/S
B
M
n2 LP
S
50
/S
+L P
PS
/S
M
n2 LP P
50 S/U
+L
O
PS
/U
O

V
eh
ic
l
M e
n2
50
M
n2 pI:
50 C
+p
I
pI :C
M :C
n2 /S
50 B
+p
I:
M
C
n2 pI:
C
50
/
+p SP
I:
C
/S
M
p
n2
I: P
50 C /
+p UO
I:
C
/U
O

0

1400

1200
D
1100
1000
900
800
800
700
600
500
400
300
200
100
0

c

C

1200

TNF-α (pg/ml)

b

b

1600

d

600

c

B

1000
800
500

b
e

400
300
200

a

100

d
g
f

g

f

M
n2
50
M
n2 Cp
50 G
+C
pG
M
n2 Cp
50 G/
+C SB
pG
/S
M
B
n2 Cp
G
50
/
+C SP
pG
/S
M
n2 Cp P
5 0 G/
+ C UO
pG
/U
O

e
ic
l
eh
V

Figure 4.4

e
b
a

d

f

g

f

g

V
eh
ic
l
M e
n2
50
M
n2 GP
50 G
+G
P
M
n2 GP G
50 G/
+G SB
PG
/S
M
B
G
n2
P
5 0 G/
+G SP
PG
/S
M
G
n2
P P
50 G/
+G UO
PG
/U
O

0

c

Effect of exposure to SB203580 (SB, p38 inhibitor), SP600125 (SP, JNK
inhibitor), and UO126 (UO, ERK inhibitor) on Mn-potentiation of LPS,
pI:C, CpG, or GPG-activated microglial TNF-α production.
TNF-α production was analyzed in N9 microglia exposed for 1 h to 25
µM of SB, JNK, or ERK, followed by exposure to 250 µM Mn and/or 100
ng/ml LPS (A), 50 µg/ml pI:C (B), 200 nM CpG (C), or 5 µg/ml GPG
(D). Media levels of TNF-α and IL-6 were analyzed by respective
DuoSet ELISA as described in Materials and Methods. Data shown in
each bar represent the mean ± SEM, of 4 independent replicates. a,b,c,d,e,f,g
Presence of letters on top of bars indicate treatment differences in the
TNF-α levels with bars with different letters being different from each
other and from bars without a letter (p ≤ 0.05).
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Figure 4.5

a

Effect of exposure to SB203580 (SB, p38 inhibitor), SP600125 (SP, JNK
inhibitor), and UO126 (UO, ERK inhibitor) on Mn-potentiation of LPS,
pI:C, CpG, or GPG-activated microglial IL-6 production.
IL-6 production was analyzed in N9 microglia exposed for 1 h to 25 µM
of SB, JNK, or ERK, followed by exposure to 250 µM Mn and/or 100
ng/ml LPS (A), 50 µg/ml pI:C (B), 200 nM CpG (C), or 5 µg/ml GPG
(D). Media levels of IL-6 were analyzed by respective DuoSet ELISA as
described in the Materials and Methods. Data shown in each bar represent
the mean ± SEM, of 4 independent replicates. . a,b,c,d,e,f,g Presence of
letters on top of bars indicate treatment differences in the IL-6 levels with
bars with different letters being different from each other and from bars
without a letter (p ≤ 0.05).
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Discussion
Several previous studies have shown that Mn can enhance, or potentiate, LPSinduced inflammatory mediator production in glial cells (Chang and Liu, 1999; Filipov et
al., 2005; Chen et al., 2006; Crittenden and Filipov, 2008). Additionally, it has been
demonstrated that Mn-potentiation of neuroinflammation is dependent on NF-kB, and is
associated with persistent p38 activation (Filipov et al., 2005; Crittenden and Filipov,
2008). However, it is not clear if these effects are limited to a specific inflammagen (i.e.
LPS) or activating receptor/pathway (i.e. TLR4). It has already been shown that primary
microglia, both human and murine, produce TNF-α and IL-6 in response to stimulation
with GPG, pI:C, LPS, and CpG which are ligands for TLR 2, TLR3,TLR4, and TLR9,
respectively (Olson and Miller, 2004; Jack et al., 2005; Town et al., 2006). In the current
study, following TLR stimulation, we observed similar increases in TNF-α and IL-6, as
was observed for primary microglia (Olson and Miller, 2004; Jack et al., 2005; Town et
al., 2006), suggesting that this (N9) cell line behaves similar to primary microglia.
Moreover, the current results clearly demonstrate that not only does Mn-potentiation
occur in TLR-stimulated N9 microglia for several TLR ligands, but that it does so in a
dose-responsive manner (Figures 4.1 and 4.1B). Importantly, this suggests that Mnpotentiation is not dependent on MyD88, a common signaling adaptor for TLR2, TLR4,
and TLR9, but not TLR3.
Of note, the increase in TNF-α and IL-6 due to the combination of Mn+TLRligand is not limited to protein expression, as increased mRNA was observed at 4 h for
each cytokine (Figures 4.2A and 4.2B). Interestingly, although Mn-potentiated TNF-α
mRNA for LPS, pI:C, CpG, and GPG-stimulated cells, IL-6 mRNA was only statistically
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potentiated for LPS and pI:C (Figures 4.2A and 4.2B). This suggests that Mnpotentiation of CpG- and GPG-induced IL-6 production may not be entirely due to
enhanced transcription of IL-6 mRNA. It should be noted that Mn alone did not increase
cytokine protein or mRNA (Figures 4.1 and 4.2) to any major extent, suggesting that Mnpotentiation of TLR-induced cytokine mRNA and protein expression requires activation
of a TLR-signaling pathway by a TLR agonist.
Previously, we have reported that Mn-potentiation of LPS-induced inflammatory
cytokine production is associated with prolonged p38 activity (Crittenden and Filipov,
2008). In the present study, p38 phosphorylation was greatest in Mn+TLR-ligand
exposed cells. Furthermore, the increased p38 phosphorylation persisted up to 4 h after
initial exposure, unlike the TLR-ligands alone which were not significantly increased at 4
h in comparison to vehicle control (Figures 4.3A). Of note, no significant differences
were observed for non-phosphorylated p38 for any of the TLR-ligands, alone or in
combination with Mn, which suggests the observed increase in p38 activation was not
associated with changes in protein expression for p38 (Figure 4.3A).
As we have also previously reported, p38 phosphorylation in response to LPS
stimulation is elevated at 1 h, but diminishes by 4 h (Crittenden and Filipov, 2008). In
this study, we examined p38 phosphorylation at 1 h for another TLR ligand, pI:C, which
has differential signaling from that of LPS. Increased phosphorylation of p38 was
observed at 1 h for pI:C-stimulated N9 microglia relative to vehicle, however it was less
than Mn and pI:C in combination (Figure 4.3B). Similar to LPS alone as previously
reported (Crittenden and Filipov, 2008), pI:C-induced p38 phosphorylation decreases by
4 h, suggesting that prolonged p38 phosphorylation is important for the enhanced
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inflammatory cytokine production observed for the pI:C-Mn combination and may be
important for Mn-potentiation of CPG- and GPG-induced TNF-α and IL-6 as well.
The relevance of the previous observations is underscored by the fact that each
TLR (i.e. TLR2, TLR3, TLR4, and TLR9) utilizes somewhat different signaling
pathways (Beutler, 2004; Takeda and Akira, 2004). In the case of pI:C, a distinctly
different pathway is utilized, as pI:C-TLR3 signaling is not mediated by MyD88, but uses
the TRIF adaptor molecule instead (Beutler, 2004; Takeda and Akira, 2004). Thus, the
Mn-potentiation effect is not dependent on a specific signaling pathway. As Mn
potentiates pI:C-induced TNF-α and IL-6, it seems likely that Mn-potentiation of TLRinduced inflammatory cytokine production is independent of MyD88. However, as CpGand GPG-signaling occurs through TLR9 and TLR2 (respectively), and since both of
these TLRs are believed to require the adaptor molecule MyD88 (Beutler, 2004), Mnpotentiation may utilize either MyD88 or TRIF.
Another likely target for Mn-potentiation of microglial inflammatory cytokines is
the family of ‘downstream’ signaling kinases, p38, ERK, and JNK. We have previously
demonstrated that pharmacological inhibition of p38, and to a much lesser degree ERK,
prevented enhanced inflammatory cytokine production in Mn+LPS-exposed N9
microglia (Crittenden and Filipov, 2008). Additionally, research by Chen et al. (2006)
reported not only Mn-potentiation of TNF-α in LPS/IFN-γ-stimulated primary mixed glia
and increased phosphorylation of multiple (p38, ERK, JNK) kinases, but also that
pharmacological inhibition of p38 prevented the potentiating effect of Mn. .
While our previous data regarding p38 activation is in agreement with others
(Chen et al., 2006), we have not extensively examined the role(s) of ERK or JNK. It has
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been reported that inhibition of ERK by UO126 was effective at preventing Mnpotentiation (Chen et al., 2006). This is in contrast to our previous studies using the ERK
inhibitor, PD98059, which was not as effective as the p38 inhibitor SB203580 at
preventing Mn-potentiation. As the ERK inhibitor PD98059 prevents activation of the
inactive MKK ‘upstream’ of ERK, but not the activated MKK (Favata et al., 1998), it is
possible that incomplete inhibition of the MKK responsible for phosphorylating ERK
may have underplayed the role of ERK in IL-6 and TNF-α production in Mn+LPSexposed cells. To that end, using the ERK inhibitor UO126 that is reported to inhibit
both inactive and active MKK (Favata et al., 1998) may provide more information
regarding the role of ERK in Mn-potentiation of TLR-induced cytokine production.
Additionally, although it has been demonstrated that the JNK inhibitor SP600125 can
prevent inflammatory cytokine synthesis in cells of the innate immune system, we have
not previously examined this role of the JNK signaling pathway in Mn-potentiation of
TNF-α and IL-6 by TLR-stimulated N9 microglia (Waetzig et al., 2005; Zhou et al.,
2007).
To determine if ‘partial’ ERK inhibition may have been responsible for the
incomplete inhibition of Mn-potentiation that we previously observed in our experimental
model, as well as to examine the role of JNK, we exposed N9 microglia to inhibitors for
p38, JNK, and ERK prior to exposure to Mn and/or TLR-ligands (LPS, pI:C, CpG, or
GPG). Although all MAPK inhibitors (SB203580, SP600125, and UO126) were
effective at preventing Mn-potentiation of TNF-α or IL-6, we observed a differential
effect of MAPK inhibition among the TLR tested. Inhibition of Mn-potentiation for
TNF-α and IL-6 in TLR2, TLR4, and TLR9-stimulated cells was greatest for the JNK
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and ERK inhibitors, in contrast to TLR3 where p38 and JNK inhibition was most
effective.
For TLR4 (LPS), this is somewhat in contrast to our previous work, but in
agreement with Chen et al. (2006) who reported that prior exposure to SB203580,
UO126, or SP600125 inhibited LPS- and Mn+LPS+IFN-γ-induced TNF-α production by
mixed glia equally (Chen et al., 2006). In the case of ERK, this may be due to the
differences in the mechanism of action of the MAPK inhibitors (PD98059 vs. UO126).
Although the role of the MAPK in Mn-potentiation of TLR2 and TLR9-induced
inflammatory cytokines had not been previously examined, the inhibition of Mnpotentiated, TLR (CpG or GPG)-induced TNF-α and IL-6 expression in microglia preincubated with p38, JNK, or ERK inhibitors is not unprecedented, as the TLR2, TLR4,
and TLR9 receptors use a similar signaling pathway (i.e. MyD88-dependent pathway;
Takeda and Akira, 2004; Beutler, 2004). It is possible that inhibiting a target
‘downstream’ of MyD88 in one of these TLR pathways (e.g. TLR4) would have a
comparable effect on a ‘similar’ TLR-signaling pathway (e.g. TLR2 or TLR9).
On the other hand, inhibition of JNK and ERK in CpG- or GPG-stimulated cells
was more effective at preventing cytokine expression than p38 inhibition, as inhibition of
JNK and ERK almost completely inhibited TNF-α and greatly reduced IL-6. This was
not the case with TNF-α and IL-6 production in cells exposed to SB203580 followed by
Mn+TLR (i.e. LPS, CpG, GPG), in that cytokine production was significantly inhibited,
but not as much as with SP60125 and UO126. This could be explained by the
observation that both TLR2 and TLR9 require MyD88 for intracellular signaling, while
TLR4 can initiate intracellular signaling by a MyD88-dependent or –independent
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pathway (Beutler, 2004; Takeda and Akira, 2004). It may be that MyD88-mediated
signaling by TLR2 and TLR4 activation primarily utilizes JNK and ERK. Toll-like
receptor 4-signaling, on the other hand, can initiate signaling by two different pathways,
which increases the diversity of ‘downstream’ targets (Barton and Medzhitov, 2003;
Beutler, 2004). Thus, TNF-α production in TLR4-stimulated cells is less dependent on
individual intermediate signaling molecules (i.e. p38, JNK, or ERK).
Interestingly, Mn-potentiation of TLR3 (pI:C)-induced TNF-α and IL-6 is most
sensitive to inhibition of p38 and JNK. As TLR3 is believed to be MyD88-independent,
it may be that this signaling pathway primarily uses p38 and JNK to mediate intracellular
signaling (Takeda and Akira, 2004; Beutler, 2004). However, as was observed overall
for TLR2, TLR4, and TLR9-stimulated cells, inhibition of all three MAPKs was at least
partially effective in preventing enhanced inflammatory cytokine production.
In summary, Mn-potentiation of TLR-induced inflammatory cytokines is not
limited to LPS-stimulated microglia, and Mn-potentiation can occur for a broad array of
TLR (i.e. pI:C, CpG, and GPG). Manganese-potentiation is not MyD88-dependent, as
TNF-α and IL-6 production is potentiated in TLR3 (pI:C)-stimulated microglia, which is
a MyD88-independent signaling pathway. Prolonged p38 phosphorylation is associated
with Mn-potentiation in TLR (LPS, pI:C, CpG, GPG)-stimulated N9 microglia.
Pharmacological inhibition of p38, ERK, and JNK inhibited inflammatory cytokine
production in all TLR (LPS, pI:C, CpG, GPG)-stimulated cells, suggesting one or more
of the MAPK are involved in TLR-mediated TNF-α and IL-6 production, as well as in
the Mn-potentiation of these cytokines.
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CHAPTER V
CONCLUSIONS
One of the fundamental biological tenets is the interaction of different cell types
within the multicellular milieu of tissues and organs. The exchange of information in the
form of neurotransmitters, hormones, cytokines and many other biomolecules, in
appropriate concentrations and duration, allows cells to promote growth and development
within the tissue and between organs, thereby promoting the fitness of the organism.
However, excessive or prolonged expression of these molecules, as observed with
inflammation, may be detrimental to cells and tissues, promoting cellular damage and
death. Interestingly, the latter concept is similar to a fundamental tenet of toxicology, as
the difference between a cure and a poison is attributed to the dose a chemical (reviewed
in Ames and Gold, 2000). In the current study, we have attempted to address how
exposure to a toxicologically relevant metal, such as Mn, results in enhanced and
prolonged expression of inflammatory cytokines, with an emphasis on intracellular
signaling, as this may provide insight into the mechanism of action, as well as potential
targets for therapeutic intervention in cases of excessive Mn exposure.
Although it has been reported that Mn alone can induce mild to moderate
expression of inflammatory mediators in non-activated glia (Bae et al., 2006; Zhang et
al., 2007), the greatest effect has been observed in LPS- or LPS/INF-γ-activated glia.
Indeed, production of cytokines and NO in LPS-activated microglia is potentiated by Mn,
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typically resulting in 2-fold or more increases in inflammatory mediators relative to LPS
alone (Barhoumi et al., 2004; Filipov et al., 2005; Crittenden and Filipov, 2008).
However, whether Mn-potentiation is dependent on activation of the TLR4-signaling
pathway, or a specific molecular component, is not clear. To demonstrate that Mnpotentiation is not limited to LPS-induced activation, we have shown that Mnpotentiation of microglial cytokine production can occur in cells activated by pI:C, CpG,
or GPG, ligands for TLR3, TLR2, and TLR9, respectively (Figure 4.1). Additionally,
we have demonstrated that the potentiation is not dependent on time of exposure, as
exposure to Mn 3 h before or after microglial activation will result in enhanced IL-6 and
TNF-α production (Figure 2.1). Taken together, Mn-potentiation is not dependent on
activation by a specific TLR ligand (i.e. LPS, pI:C, CpG, or GPG) and is not limited to a
narrow window of exposure, suggesting that exposure to Mn could occur before or after
exposure to various TLR ligands.
On the other hand, activation of the CNS inflammatory cells may not be
dependent on direct stimulation of microglial TLR. It has been shown that peripheral
inflammation can induce activation of cellular inflammation in the CNS (Perry et al.,
1998; Cunningham et al., 2005). It is possible that induction of peripheral inflammation
can trigger neuroinflammation and, if Mn exposure has occurred/is occurring as well, the
result could be an enhanced and prolonged inflammatory cytokine production in the
brain. Although an intriguing hypothesis, there is no published data to support this
possibility at the present time.
As the first reports to describe the potentiation effect were in glia co-exposed to
Mn and LPS, with or without IFN-γ, (Spranger et al., 1998; Chang and Liu, 1999;
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Barhoumi et al., 2004), the TLR4 signaling pathway appeared to be the logical candidate
for the site of action of Mn. Some of the early studies clearly demonstrated a role for
transcription factors like NF-kB, as well as signaling kinases like the MAPK, which are
both components of the TLR4 signaling pathway (Chang and Liu, 1999; Filipov et al.,
2005; Bae et al., 2006; Crittenden and Filipov, 2008). Therefore, we initially examined
two of the MAPK thought to be critical for production of inflammatory mediators by
microglia, p38 and ERK (Koistinaho and Koistinaho, 2002). We investigated the role of
p38 and ERK using pharmacological inhibitors specific for each of these MAPK,
SB203580 and PD98059, respectively. From this work, we concluded that p38, and not
ERK, was primarily responsible for the Mn-potentiation we had observed. This data was
in general agreement with the perceived role of p38 in stress and inflammation, while
ERK appeared not to be as important in the observed Mn-potentiation (Koistinaho and
Koistinaho, 2002).
However, published work by others using mixed glia or primary microglia
suggested that, besides p38, JNK and ERK were also involved in the production of
inflammatory mediators by microglia (Bae et al., 2006; Liao et al., 2007; Zhang et al.,
2007). Since we had not previously examined the role of JNK in our experimental
system, we decided to assess the role of JNK using pharmacological inhibition (i.e.
SP600125), as well as re-examine the role of ERK using a different pharmacological
inhibitor, UO126. Although our early investigations suggested that p38 was, perhaps,
most involved in the observed Mn-potentiation, pharmacological inhibition of any of the
three major MAPK prevented both TLR- and Mn+TLR-induced inflammatory cytokine
expression. This work was somewhat in contrast to our previous findings with ERK,
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which may be due to incomplete inhibition of ERK by PD98059 as it only targets
inactive ERK, while UO126 inhibits both inactive and active ERK (Favata et al., 1998).
Additionally, both SB203580 (p38) and SP600125 (JNK) prevented Mn-potentiation in
LPS-activated N9 microglia.
Taken together, pharmacological inhibition of the MAPK (i.e. p38, ERK, or JNK)
will inhibit Mn-potentiation in TLR-activated N9 microglia. Although p38 may not be
the only MAPK involved in the Mn-potentiation of inflammatory cytokines, activation of
p38 and its downstream targets like the cytokine transcription factor TATA-binding
protein (TBP), as well as activation of NF-kB, is necessary for TNF-α expression (Carter
et al., 1999). We have demonstrated that Mn exposure not only increases p38 activation
(i.e. phosphorylation), but also increases p38 kinase activity in LPS-activated N9
microglia. Moreover, as p38 kinase activity is responsible for activating transcription
factors necessary for cytokine synthesis such as TBP (Carter et al., 1999), it is possible
that enhanced p38 phosphorylation and kinase activity may result in increased
inflammatory cytokine mRNA and protein expression. Indeed, we have observed Mndependent increases in TNF-α mRNA and protein expression in LPS-activated N9
microglia. However, it is not clear if Mn effects TBP activation and/or nuclear
translocation, as we have not examined activation of TBP at this time.
On the other hand, the role of JNK and ERK cannot be overlooked, as these
MAPK play a role in the expression of inflammatory mediators by activated microglia
(Waetzig et al., 2005; Wu et al., 2007). Although our current data is in general
agreement with the literature, it is not clear if one or more of the MAPK is of greater

102

importance than the others in the Mn-potentiation of inflammatory mediators we have
observed.
Another important question is what is responsible for the enhanced and prolonged
activation of p38, and perhaps the other MAPK? As activation of the MAPK is thought
to be dependent on the upstream MAP2K, we have examined the MAP2K primarily
responsible for activating p38, MEK-3/6. In addition, we have examined two other
MAP2K that may be important in the activation of p38, as well as ERK and JNK, MEK1/2 and MEK-4, respectively. Although MEK-3/6 activation was not significantly
changed by the presence of Mn, we did observe a small but significant increase in the
phosphorylation of MEK-1/2 and MEK-4 at 1 h that diminished by 4 h. It is possible that
the enhanced p38 phosphorylation observed at 4 h is due, in part, to increased activation
of MKK-1/2 and MKK-4. However, as MKK-3/6 is considered the primary MAP2K
responsible for activating p38, and because increased activation of MKK-1/2 or MKK-4
is not observed at 4 h, enhanced MAP2K activity may not be primarily responsible for
the prolonged activation of TLR-activated, Mn-exposed microglia. An alternative to
MAP2K activation of p38 is ‘autophosphorylation’, which requires p38 to associate with
the TAK1/TAB1 complex (Ge et al., 2002). However, we have not examined this
possibility within our experimental model.
Another mechanism whereby Mn can prolong the activation of p38 is by acting
on the phosphatase MKP-1. This may be important in the context of Mn-potentiation, as
decreased MKP-1 was observed at 1 h in Mn-exposed cells. However, by 4 h the levels
of MKP-1 mRNA and protein had significantly increased relative to controls. Typically,
MKP-1 expression coincides with p38 activation, to serve as feedback control, thereby
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preventing prolonged activity of p38 and enhanced expression of inflammatory
mediators. In fact, we did observe increased MKP-1 expression at 1 h in LPS-exposed
cells; however the magnitude of the increase was decreased substantially in cells exposed
to Mn and LPS. This is in contrast to N9 microglia exposed to Mn, which had less MKP1 mRNA and protein expression. Taken together, the initial decrease in MKP-1
expression could result in enhanced activation of p38. Furthermore, the delay in ‘normal’
feedback inhibition may result in increased MKP-1 at a later time point, as the signaling
pathway within the cell works to deactivate p38. Indeed, this is what we observed at 4 h
for MKP-1 in Mn-exposed cells. Although the decreased MKP-1 mRNA and protein in
cells exposed to Mn may result in prolonged activation of p38, further examination of
MKP-1 activation and enzymatic activity is necessary to determine if decreased MKP-1
expression is responsible for the persistent activation of p38.
In contrast to the role of the MAPK in Mn-potentiation of IL-6 and TNF-α,
specific TLR activation is not required for enhanced inflammatory cytokine in the
presence of Mn. This is relevant as activation of TLR2, TLR4, and TLR9 are dependent
on the adaptor molecule MyD88, while MyD88-independent signaling via TLR3 requires
TRIF. Thus, potentiation of inflammatory cytokines by Mn in TLR-activated microglia
is not dependent on MyD88 activation. It may be that Mn acts ‘downstream’ of the
initial TLR signaling pathway, suggesting that the MAPK, or another signaling
pathway(s) intersecting with the MAPK, may be the molecular site of action.
On the other hand, Mn-potentiation of inflammatory cytokine protein may not be
due to increased mRNA expression alone. Activation of the p38 MAPK signaling
pathway not only increases inflammatory cytokine gene expression, but may also
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promote mRNA stability, resulting in an increased half-life of the cytokine mRNA (Sun
et al., 2007). Indeed, p38 phosphorylation of downstream targets like MAPK activated
kinase-2 (MK-2), as well as tristetraprolin (TTP), is necessary for preventing TNF-α
mRNA degradation (Sun et al., 2007). The enhanced p38 activation observed in Mnexposed N9 microglia may increase cytokine protein by not only increasing mRNA
expression, but also by increasing cytokine message stability.
In summary, (i) Mn-potentiation of inflammatory cytokine expression is not
dependent on microglial activation by a specific TLR, or the TLR adaptor protein
MyD88, (ii) activation of downstream signaling targets such as p38, ERK, and JNK
appear to be necessary for enhanced cytokine mRNA and protein expression and (iii)
increased and prolonged p38 activation partly due to the effects of Mn on MKK-1/2,
MKK-4, and, importantly, MKP-1, is associated with the potentiating properties of Mn.
Further examination of the MAPK cascade may provide important data in regards to Mnpotentiation of IL-6 and TNF-α. Specifically, examining alternative p38 activation
mechanisms (i.e. autophosphorylation), as well as the activation of ERK and JNK, may
indicate the molecular target for Mn-induced inflammatory cytokine potentiation.
Additionally, examination of the molecular targets of p38, and perhaps ERK and JNK,
may indicate whether the Mn-potentiation of inflammatory cytokines in TLR-activated
microglia is mainly due to enhanced cytokine mRNA expression and/or to increased
cytokine mRNA stability as well.
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